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The aim of this study was to investigate Leptospira as a possible aetiology of chronic 
kidney disease (CKD), as well as investigating the relationship between demographic, 
haematological, biochemical, urinary and other variables, with leptospiral infection, in 
cats. 
In this retrospective study, whole blood samples of 158 cats of the feline population of 
Langford Vets, Bristol, between September 2016 and October 2017, were analysed 
using a real-time polymerase chain reaction assay (qPCR) targeting the lipL32 gene, 
present in pathogenic Leptospira. 
When analysing the relationship between CKD and leptospiral positivity, 69 cats were 
excluded due to having existing conditions known or suspected to cause CKD. Of the 
remaining 89 cats, 2/33 (6.06%) of ‘CKD’ cats and 6/56 (10.71%) of ‘non-CKD’ cats 
were deemed leptospiral positive by PCR. There was found to be no significant 
association between CKD and leptospiral positivity. 
All cats were included (n=158) when analysing the relationship between other 
variables and leptospiral positivity. 24/158 (15.19%) cats were deemed leptospiral 
positive. Statistical analyses revealed that leptospiral positive cats had significantly 
higher basophil and lymphocyte counts, as well as higher serum alanine 
aminotransferase. Leptospiral positivity was also significantly associated with AKI, 
current urolithiasis/nephrolithiasis, eosinophilia and lymphocytosis and biochemical 
hyperthyroidism. A negative correlation was found with age, abnormally low total 
protein and biochemical hypothyroidism. 
Although, this study failed to demonstrate an association with leptospiral positivity and 
CKD, it was associated with AKI and younger cats. Younger cats may be more 
susceptible to infection by the bacterium, before an effective immune response is 
elicited, which then adapts to, and prevents, future infection. This initial infection may 
cause AKI and the damage caused later progresses into CKD as a cat gets older, 
despite the absence of active leptospiraemia by this point. Therefore, leptospiral 
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1.1 Feline Chronic Kidney Disease 
Chronic Kidney Disease (CKD) can be defined as the ‘structural and/or 
functional impairment of one or both kidneys that has been present for more 
than approximately 3 months’ (Bartges 2012). Acute kidney damage or acute 
kidney injury (AKI), describes a condition that occurs suddenly, usually as a 
result of impairment of the tubular region of the kidneys and can be caused by 
certain nephrotoxic drugs or anaesthetic conditions (Grauer 2005), as well as 
urethral obstructions, dehydration and infectious causes (Ross 2011, Mugford, 
Li and Humm 2013) . If the resulting lesions are severe, it may lead to acute 
kidney failure and a poor prognosis. However, If the patient survives this acute 
insult, it can later progress to chronic kidney disease, as shown in one study in 
99 dogs with acute renal failure (also known as AKI) (Vaden, Levine and 
Breitschwerdt 1997) in which 24 of the 43 that survived went on to develop a 
chronic kidney condition. CKD is predominately recognised as a geriatric 
disease amongst cats (Reynolds and Lefebvre 2013), with one study reporting 
the average age of cats diagnosed with CKD as 15 years (Bartlett et al. 2010). 
The underlying cause can initiate damage to any of the areas of the kidney in 
order for it to lose its function and once a large proportion of nephrons are non-
functional, chronic kidney failure develops (Grauer 2005). Although also 
reported in dogs (Bartlett et al. 2010, Polzin 2013), it is recognised as the most 





Presence of azotaemia, continuous proteinuria and poorly concentrated urinary 
output on laboratory findings combined with the appropriate history and findings 
on clinical examination, is cause for diagnosis of CKD (Grauer 2015, Bartges 
2012). 
1.1.1.1 Clinical signs 
Clinical signs indicative of the disease include polyuria/polydipsia, anorexia, 
lethargy, weight loss, vomiting, dehydration, constipation and halitosis (Acierno 
and Senior 2010, Reynolds and Lefebvre 2013, Elliott and Barber 1998, 
Greene et al. 2014). Studies report that anaemia is the most commonly seen 
consequential condition, especially in the later stages of the disease (Elliott and 
Barber 1998, King et al. 2007); this is thought to be due the reduced or absent 
production of erythropoietin by the kidneys. Loss of sight, secondary to 
hypertension caused by CKD can also occur (Acierno and Senior 2010), 
although this is thought to be rare with one study reporting blindness in only 
1/80 cats with chronic kidney failure (Elliott and Barber 1998). One literature 
review acknowledged haematuria, difficulty urinating, abnormal faeces and 
neurological abnormalities as less commonly seen clinical manifestations 
(Reynolds and Lefebvre 2013). The earliest signs seen in cats is polyuria and 
polydipsia with one case-control study showing that this symptom developed in 
most in the year prior to diagnosis (Bartlett et al. 2010). Client education is 
important to enable prompt detection of the clinical signs associated with the 
disease in order to initiate earlier intervention, improving the prognosis (Paepe 
and Daminet 2013, Boyd et al. 2008)  
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Physical examination may reveal periodontal disease, as well as goitre, poor 
coat condition, cardiac murmurs, tachycardia and pale mucous membranes 
(Elliott and Barber 1998). In a retrospective case-control study, Greene et al. 
discovered that diagnosis of CKD was more likely in cats that had been 
reported to have periodontal disease or cystitis in the year prior to diagnosis 
(Greene et al. 2014). On palpation of the kidneys, either unilateral or bilateral 
reduction in size, has been associated with end-stage CKD (Elliott and Barber 
1998). 
1.1.1.2 Laboratory findings 
Biochemistry, haematology and urinalysis tests can be performed to diagnose 
the disease, especially in the advanced stages (Paepe and Daminet 2013). 
Problems identified from these tests include proteinuria, elevated serum 
creatinine and urea, anaemia, isothenuria, metabolic acidosis, 
hyperphosphataemia, hypokalaemia, lymphopaenia, hypercholesterolaemia 
and microalbuminuria (Paepe and Daminet 2013, Lees et al. 2005, Bartges 
2012). Elliot and Barber also reported increasing blood sodium levels and 
cholesterol levels, decreasing chloride levels and decreasing packed cell 
volume (PCV), with advancement of disease (Elliott and Barber 1998). 
Hypernatraemia was suggested to be due to a decrease in water intake as the 
disease progresses and the hypercholesterolemia due to disrupted lipid 
breakdown seen with kidney disease. Hypokalaemia can be common in the 
earlier stages, however, in the later stages, hyperkalaemia may also be evident 




Urine specific gravity (USG) is a measure of how concentrated the urine is and 
can be measured using refractometry (Watson 1998). A literature review stated 
that most cats with CKD will have isothenuric urine measuring between 1.007-
1.015 although this may not be evident until the later stages of the disease 
(Paepe and Daminet 2013). In a study measuring USG in healthy non-
azotaemic cats and azotaemic cats with CKD, it was found that it was 
significantly lower in the latter group with an average of 1.022 (Williams and 
Archer 2016). An Initial reading of USG on presentation has been found to have 
no significant association with survival time (King et al. 2007). It is also 
recommended to take into account the fact that this value is likely to undergo 
daily changes in any animal and unless it comes hand in hand with some of the 
other signs, it may not necessarily indicate CKD (Paepe and Daminet 2013). 
Some have argued, that due to findings in cats that have undergone renal 
ablation, USG is not an adequate marker of kidney function (Finch 2014). GFR 
measurement using renal clearance and plasma clearance methods may be a 
more effective measure of renal function (Finch 2014), although this is not as 
simple to implement in practice. Measurement of urinary protein: creatinine 
ratio (UP/C) has also been concluded to be an important factor in diagnosis, by 
predicting the level of proteinuria present with higher levels also being 
associated with shorter survival times (King et al. 2007). 
1.1.1.3 Staging 
Once diagnosed, CKD can then be staged according to the International Renal 
Interest Society (IRIS) guidelines (IRIS 2015). It is staged based mainly on the 
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presence and severity of azotaemia, although uses measurements of blood 
pressure and proteinuria for further sub staging.  
Stage 1 refers to a non-azotaemic cat with a blood creatinine level of 
<140μmol/l with other mild renal abnormalities present such as poor urinary 
concentration. Stage 2 represents a mild azotaemia with a blood creatinine 
level of 140-250μmol/l with mild or no clinical signs present. Stage 3 cats suffer 
from moderate azotaemia with a blood creatinine level between 251-440μmol/l 
with the presence of more severe clinical signs. Cats with stage 4 CKD, also 
known as end stage, have a blood creatinine level above 440μmol/l.  
Serum creatinine levels can also be useful for reflecting Glomerular Filtration 
Rate (GFR), although this value is also influenced by the muscle mass of an 
animal amongst other non-renal factors (Grauer 2015, Finch 2014). This should 
be considered when interpreting serum creatinine values, as well as urine 
specific gravity (USG) and physical findings to evaluate whether the azotaemia 
is caused by the kidneys alone (Grauer 2015). 
Substages representing levels of proteinuria class non-proteinuric cats  as 
having a urine protein to creatinine (UP/C) ratio of <0.2, borderline proteinuric 
(BP) cats as having a UP/C ratio between 0.2-0.4 and proteinuric (P) cats as 
having a ratio >0.4 (IRIS 2015). Increase in these values seen with progression 
of the disease are thought to be of consequence of glomerular lesions, with or 
without tubular lesions (Grauer 2015). Higher UP/C ratios are significantly 
associated with shorter survival times in cats with CKD (King et al. 2007). 
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Furthermore, arterial blood pressure can be analysed to further substage the 
groups by assessing risk of damage to the organs secondary to hypertension 
(IRIS 2015). Systolic blood pressure (mmHg) is <150, 150-179, ≥180, in 
minimal risk, low to moderate risk, and high risk substages, respectively.  
1.1.2 Treatment 
Although CKD is an irreversible condition (Barber 2003), evidenced based 
reviews available provide information on a multidimensional approach for the 
management of feline CKD (Roudebush et al. 2009, Korman and White 2013). 
These suggest that it is important to symptomatically treat to ameliorate the 
secondary conditions that commonly occur, such as dehydration, uraemia, 
hyperphosphataemia, hypertension, hypokalaemia, proteinuria, gastric 
symptoms, malnutrition and anaemia, to slow disease progression. This can be 
done so with dietary modification, medication, fluid therapy and various dietary 
supplements. It is also important to treat any concurrent disease such as 
diabetes mellitus, urinary tract infection, osteoarthritis, dental disease and 
hyperthyroidism, all of which are seen to commonly coincide with feline CKD.  
Regular monitoring of the patient and prioritising treatment methods according 
to severity of symptoms, is important, as well as considering the quality of life of 
the animal. Although there is no cure, effective management can help prolong 




1.1.3 Aetiology of CKD 
There are numerous possible causes of CKD in cats and they can be divided 
into two groups; congenital and acquired disease.  
1.1.3.1 Congenital 
Congenital causes of CKD include polycystic kidney disease, common in 
Persian cats and their related cross-breeds (Lees 1996, Greco 2001), which 
manifests as multiple cysts found in the kidneys that grow and interfere with 
renal function. One study found that 45% of Persian cats included had evidence 
of polycystic kidney disease (PKD), but actually found a higher prevalence 
amongst exotic cats (Beck and Lavelle 2001). Breeds such as the Exotic, 
Himalayan and Oriental cats are also at high risk of developing PKD (Rodriguez 
et al. 2014).  Renal amyloidosis is a common inheritable disease in Abyssinian 
cats (Boyce et al. 1984, Lees 1996, Greco 2001), as well as Siamese, Oriental 
and Somali breeds (Lees 1996, Rodriguez et al. 2014). This is characterised by 
amyloid deposits within the kidney, commonly found in the medullary 
interstitium (Greco 2001).  
1.1.3.2 Nephrotoxins and drugs 
At the North American Veterinary Conference, clinically used drugs with 
potential nephrotoxic effects were discussed, and the management of the side 
effects evaluated (Papich 2005).Ones with the potential to cause harm to the 
kidneys include, tetracyclines, cyclophosphamide, cyclosporine, cisplatin, 
amphotericin B antibiotics, aminoglycoside antibiotics, non-steroidal anti-
inflammatory drugs (NSAIDs) and radiographic contrast agents.  
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Aminoglycoside antibiotics have been known to be a common cause of hospital 
acquired renal insufficiency in human patients (Nash, Hafeez and Hou 2002), 
as well as being nephrotoxic to small animals (Papich 2005). Their nephrotoxic 
effects may be due to the accumulation within the proximal kidney tubules 
which leads to disruption of the normal cell functions with consequential 
damage to the tubules (Papich 2005). However, one study analysing the effects 
of gentamycin on cats suggested that if given at the recommended daily dose, 
had little impact on renal function, but nephrotoxicity was more evident if this 
dosage was doubled (Hardy, Hsu and Short 1985). 
The long term administration of NSAIDs can also have a negative impact on the 
kidney function of animals (Papich 2005). This is due to the inhibition of 
prostaglandin synthesis that results from these drugs, their role in tubular 
function and vascular tone is compromised and can cause kidney damage. 
However, it is thought that only those animals already suffering from renal 
dysfunction prior to administration would experience any of these negative side 
effects. One retrospective study found that NSAIDs such as meloxicam, 
commonly used to treat degenerative joint disease in cats, may not have 
nephrotoxic impact if administered at a lower median daily dose (Gowan et al. 
2011). This study suggested that NSAID therapy may even slow the 
deterioration of a cat suffering from stable CKD, although it was unknown if this 
was due to direct effect on the kidneys or due to the alleviation of symptoms 
seen with the concurrent degenerative joint disease (DJD) occurring with the 
cats in this study. The patenty of its use, as with its salt derivatives, in the 
treatment of feline CKD is currently being applied for (Johnston 2011). Other 
drugs licensed in cats include Carprofen, ketoprofen, robenacoxib, and 
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tolfenamic acid and acetylsalicyclic acid, depending on region (Sparkes et al. 
2010). 
Lilies too, can have hugely detrimental effects on the kidneys of cats, with even 
small amounts eaten causing fatalities (Fitzgerald, 2010). This is thought to be 
a consequence of water soluble components targeting the tubular epithelium, 
being rapidly absorbed, causing acute kidney damage. Ingestion of ethylene 
glycol, commonly found in antifreeze solution, can lead to oliguric renal failure 
in cats, if not treated promptly (Balakrishnan and Drobatz 2013). The oxalates 
and glycolic acid formed by a cascade of reactions are the major contributors to 
acute tubular necrosis (Balakrishnan and Drobatz 2013). Persistent insult by 
these toxins or insufficient recovery after acute kidney injury could go on to 
cause CKD (Reynolds and Lefebvre 2013).  
1.1.3.3 Viral 
As seen with Human Immunodeficiency Virus (HIV), neuropathies have been 
associated with the feline lentivirus, Feline Immunodeficiency Virus (FIV) (Poli 
et al. 2012). When studying experimentally and naturally FIV infected cats, Poli 
et al. found that the histology and laboratory findings suggested the lentivirus to 
be a cause of the renal abnormalities. One study found that proteinuria was 
commonly found in cats infected with FIV compared to non-infected cats, 
although there was no association between azotaemia and FIV (Baxter et al. 
2012). Others have found an association between the FIV and kidney 
dysfunction and although some have found a direct link (Poli et al. 1995) others 





It has been reported that cats suffering from hyperthyroidism can develop 
azotaemic kidney disease after receiving treatment for the primary disease 
(Williams et al. 2010, Adams et al. 1997b, van Hoek et al. 2009). When 
exploring the mechanism for this, Williams et al. investigated the role of 
vascular endothelial growth factor (VEGFR), which was previously found to 
help maintain blood vessels and the renal vasculature (Williams, Elliott and 
Syme 2014). By monitoring its urinary excretion as a marker, this study 
concluded that although the hyperthyroidism indirectly leads to increased renal 
production of VEGFR (a marker of tubular hypoxia) via the renin-angiotensin-
aldosterone system (RAAS), it was not associated with the development of 
CKD, and so the mechanism for the link between the two diseases remains 
unclear. Interestingly, CKD has been found to decrease the amount of total 
thyroxine concentration seen and conceal the effects of hyperthyroidism 
(Peterson and Gamble 1990) and in turn, there is evidence suggest that 
hyperthyroidism leads to a decrease in creatinine values via decreased muscle 
mass and increased glomerular filtration rate (GFR), leading to a misdiagnosis 
of CKD (Adams, Daniel and Legendre 1997a, Becker et al. 2000, Vaske, 
Schermerhorn and Grauer 2016).   
1.1.3.5 Neoplasia 
Another condition that causes specific renal lesions is lymphoma (Quimby 
2015). Renal lymphoma was found in 10.6% of cats with organic kidney failure 
(Minkus et al. 1994) and is thought to be a potential cause of CKD in cats 
(Reynolds and Lefebvre 2013). A study in 118 cats diagnosed with 
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lymphosarcoma, 30% of the cases were found to have renal involvement 
(Gabor, Malik and Canfield 1998). A later report on the same cohort 
investigated the haematological and biochemical values of these cats (Gabor, 
Canfield and Malik 2000). Common findings in these cats with renal 
involvement showed evidence of anaemia, raised serum and creatinine levels, 
as well as azotaemia, being more significant in cats with renal associated 
lymphoma, which could be attribute to the ongoing renal dysfunction caused by 
the neoplasia. 
1.1.3.6 Urolithiasis and nephrolithiasis 
Urolithiasis refers to the formation of uroliths (calculi or stones) within the 
urinary tract (Gomes et al. 2018). Upper urinary tract uroliths are said to be 
associated with feline CKD (Reynolds and Lefebvre 2013). The majority of 
nephroliths (uroliths in the kidneys) and ureteroliths (uroliths in the ureters) are 
made of calcium oxalate (Berent 2011) and due the nature of this material, if it 
remains in the ureters, will lead to kidney damage. It is  difficult to assess 
whether the cats with this condition had pre-existing kidney disease or if it is a 
primary cause of the renal damage (Reynolds and Lefebvre 2013, Kyles et al. 
2005). One study found that 83% of cats with ureteral calculi presented with 
azotaemia (Kyles et al. 2005) and another found it in 95% of cats presenting 
with ureteral obstruction (Berent 2011), amongst other signs indicating impaired 
kidney function. However, in a case-control study, Ross and others found that 
there was no significant effect of the presence of nephrolithiasis on progression 





Canine leptospiral infection can cause kidney damage of varying severity 
(Sykes et al. 2011, Levett 2001, Stokes and Forrester 2004) and this damage 
can persist to result in chronic kidney disease. With increasing evidence of 
leptospiral prevalence amongst cats (Section 1.2) and its similarity in clinical 
signs associated with CKD (Shropshire et al. 2015), it has become a subject of 
interest. Shropshire et al. performed the microagglutination test (MAT) on 
geriatric cats with stable CKD and geriatric cats without (Shropshire et al. 
2015). It was found in this study that there was a significantly higher 
seroprevalence of leptospirosis amongst cats without CKD. However, it has 
been proven that PCR is a more effective diagnostic tool for the disease 
(Section 1.3) with there being greater limitations in using MAT. This study also 
only included 6 serovars belonging to L.interrogans species in the MAT, which, 
considering very little is known about the aetiology and pathogenesis of this 
disease in cats, is limiting to this investigation. In contrast, an earlier study used 
PCR on urine samples from healthy cats and cats with kidney disease of 
varying severity (Rodriguez et al. 2014). It was found that seroprevalence was 
significantly higher in the kidney disease group and, although there was a 
higher number of PCR-positive cats amongst the kidney disease group, this 
was not significant. However, the PCR was performed on urine samples with 
the G1 and G2 and B64-I/B64-II primers (Rodriguez et al. 2014). Although this 
PCR technique has previously been found to be effective (Bal et al. 1994), 
limitations in using these primer sets have also been reported (Gravekamp et 
al. 1993, Parma et al. 1997). There are other reported PCR techniques, found 
to be more effective in the diagnosis of leptospirosis (Section 1.3.5). There is 
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very limited evidence regarding the possible link between leptospirosis and 




1.2  Feline leptospirosis 
Several reviews published recently have acknowledged the current lack of 
evidence surrounding feline leptospiral infection and its pathogenesis amongst 
this species (Schuller et al. 2015, Hartmann et al. 2013, Sykes et al. 2011)  
1.2.1 Seroprevalence 
In Serbia, despite there being no clinical signs of leptospirosis, out of 161 stray 
cats that were part of a neutering project, 26.7% were found positive for at least 
one serovar, the most common being Australis (then Pomona) (Obrenovic et al. 
2014). Obrenović et al. also highlighted the variation in seroprevalence of feline 
leptospirosis in different studies undertaken in various geographical locations 
including France, Austria, Iran, Scotland and Brazil. Seropositivity ranged from 
4.9-66.6%. The majority of studies available used MAT against serovars 
belonging to the L. interrogans species, commonly used in canine leptospiral 
diagnosis and it is evident that different geographical areas show a difference in 
common circulating serovar. However, due to the uncertainty that surrounds 
feline leptospirosis, MAT may be less relevant due to its specificity to canine 
infection and therefore it may prove useful to utilise a broader diagnostic tool 
allowing for deeper evaluation of infection amongst cats as there is clear 
evidence of other known pathogenic species, highlighted by one review 
(Evangelista and Coburn 2010), that could also be involved in feline infection. 
For example, when performing the MAT on the serum of stray and household 
cats in Iran (Jamshidi et al. 2009), the serovar Hardjo, Belonging to the L. 
borgspetersenii species, was included in the MAT and it was found to be the 
most common infecting serovar amongst the household cats tested. Another 
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variation amongst past studies, is the cut off value for a positive titre; some 
would deem a sample positive at a titre of 1:100 (Jamshidi et al. 2009, 
Lapointe, Plamondon and Dunn 2013, Markovich, Ross and McCobb 2012) 
whereas others may deem a titre positive when as low as 1:30 (Agunloye and 
Nash 1996). This would explain the range in seroprevalence amongst the 
different studies. Although some have implied that cats have leptospiral 
infection with a lower MAT (Markovich et al. 2012), when analysing canine 
leptospirosis, it has been suggested that using a higher minimum titre may be 
more beneficial for eliminating cross-reactivity between the serovars (Ellis 
2010). Lapointe et al. suggested that an antibody titre of >1:200 may be more 
indicative of active infection (Lapointe et al. 2013).  
1.2.2 Evidence of clinical disease 
1.2.2.1 Clinical signs 
There is a limited reported evidence of acute natural infection of leptospirosis in 
cats. Clinical signs classically associated with the canine infection may include 
anorexia, fever, lethargy, polyuria/polydipsia, weight loss and jaundice (Schuller 
et al. 2015, Sykes et al. 2011). In general, veterinarians tend to look out for 
clinical signs associated with renal/hepatic/coagulation deficits in order to make 
a differential diagnosis of leptospirosis amongst dogs (Shropshire et al. 2015).   
Although in some cases, cats shown to be infected with the disease have not 
shown any clinical signs (Ullmann et al. 2012, Harkness, Smith and Fowler 
1970), others have described signs similar to those presented amongst the 
canine species. Clinical manifestations of cases of suspected/confirmed feline 
infection include anorexia, weight loss, polyuria/polydipsia, vomiting, pyrexia, 
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lethargy and ascites (Agunloye and Nash 1996, Mason, McLachlan and King 
1972, Arbour et al. 2012, Beaudu-Lange and Lange 2014, Reilly et al. 1994, 
Bryson and Ellis 1976), most of which would indicate renal insufficiency (Elliott 
and Barber 1998). Less common clinical signs reported include oral, 
pulmonary, cutaneous, ocular and reproductive adverse effects. 
Ulcers and gingivitis (Arbour et al. 2012, Mason et al. 1972) have been reported 
in feline leptospirosis, although this can also occur in the presence of uraemia 
caused by renal disease in cats (Dokuzeylul, Kayar and Or 2016) and therefore 
could be consequence of kidney damage caused by the leptospiral infection, 
not secondary to the bacterial infection itself. 
Arbour et al. also reported a chronic uveitis in one cat (Arbour et al. 2012), a 
manifestation that has been associated with the late phase of the disease in 
dogs, horses and humans (Townsend, Stiles and Krohne 2006, Faber et al. 
2000, Chams et al. 2009). 
Reproductive repercussions such as stillbirths and abortions have been 
reported in other species of livestock and domestic animals. One literature 
review highlighted a consensus that infection with Hardjo and Pomona may 
cause abortion in cattle and pigs (Levett 2001). The only case of this reported 
in cats was in 1994 when a queen delivered stillbirth kittens (Reilly et al. 1994). 
The livers of both kittens, as well as the placenta, demonstrated the presence 
the spirochetes, which may have been responsible for this reproductive failure. 
Arbour et al. reported dyspnoea in one case of feline leptospirosis yet no 
Leptospira were found by bacterial culture of the lung tissue (Arbour et al. 
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2012). Post mortem examination of a cat in an earlier study revealed pulmonary 
haemorrhage and thrombosis in the lungs and diagnostic testing revealed 
presence of the spirochetes amongst this tissue. Similar findings have been 
reported in dogs and humans and thought to be due to leptospiral pulmonary 
haemorrhage syndrome (LPHS) (Kohn et al. 2010, Trivedi et al. 2010, Gouvela 
et al. 2008). Kohn et al. reported this in 70% of dogs with leptospirosis (Kohn et 
al. 2010) and another reported pulmonary changes by diagnostic imaging in 
57% of canine cases (Knopfler et al. 2017). 
An unusual case of feline leptospirosis occurred in France when a cat 
presented in a state of shock, with cardiac and respiratory abnormalities, as 
well as dehydration and weight loss (Beaudu-Lange and Lange 2014) and was 
found to be PCR-positive for Leptospira in blood. There was marked redness 
on the pinnae, as well as inflammation and a ‘marbled appearance’ to the skin 
on the foot digits and abdomen. Munday et al. reported the development of 
generalised cutaneous calcification in a dog over two months after its initial 
diagnosis of leptospirosis (Munday, Bergen and Roe 2005). These 
dermatological changes were hypothesised to be a consequence of a 
combination of the stress of systemic disease and renal dysfunction, leading to 
hyperphosphataemia, bacterial deposits in the skin and alteration to the dermal 
collagen. In the feline case (Beaudu-Lange and Lange 2014), a strong 
seroconversion to the serovar Saxkoebing, belonging to the serogroup Sejroë 
was reported by serology and it could be possible that this particular serovar 
could elicit this reaction. However, when beagles were experimentally infected 
with the same serovar, there were no clinical signs reported (Ruhl-Fehlert et al. 
2000). It could therefore be possible that this response in the cat was either 
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specific to the individual host, or specific to cats, during infection with that 
particular serovar. 
1.2.2.2 Liver involvement  
Jaundice, suggesting hepatic impairment, has been reported in few feline case 
reports of suspected leptospirosis and one died, whilst the others were 
euthanased due to poor prognosis (Mason et al., 1972; Rees, 1964). Both 
authors described high titres to L. Pomona amongst these cases and it could 
be that this is a clinical manifestation of this particular serovar.  
In contrast, Arbour et al. described three cats demonstrating a high titre to 
Pomona and showing no signs of hepatic dysfunction, but indications of acute 
kidney impairment, two of which fully recovered after treatment (Arbour et al. 
2012). A cat found to be MAT positive for L. Pomona, despite being in good 
condition, was destroyed for investigation following an outbreak of human 
leptospirosis to a different serovar on the farm on which it lived (Arbour et al. 
2012). Pale kidneys were noted on post mortem examination and histology 
revealed moderate interstitial nephritis as well as a generalised fatty 
parenchymal changes to the liver. This cat was thought to have become 
infected at its previous home on a farm where there had been an outbreak of 
bovine leptospirosis by L. Pomona six months previously.  
When experimentally infecting cats with L. Pomona, Fessler and Morter 
reported a subclinical infection, after having not observed any clinical signs, yet 
noted all cats as having enlarged livers on post mortem examination (last cat 
19 
 
necropsied was at 61 days post infection) as well as varying degrees of 
microscopic hepatic lesions (Fessler and Morter 1964). 
Collectively, these studies could suggest that feline leptospirosis has a long 
incubation period and jaundice could be a clinical manifestation of the very late 
stages of disease progression, particularly with this serovar.  
1.2.2.3 Laboratory and other findings 
In terms of laboratory findings of feline leptospirosis, Arbour et al. found results 
similar to that found in canine leptospirosis (Schuller et al. 2015), including 
elevated haematocrit, neutrophilia, elevated urea and creatinine, lymphopenia, 
thrombocytopenia and hyperphosphatemia (Arbour et al. 2012). On 
examination, all three patients had abnormally sized kidneys with altered 
definition and showed varied severity of renal insufficiency. Post mortem 
findings of other suspected/confirmed feline leptospirosis cases include 
interstitial nephritis, tubular nephrosis, hepatic and splenic amyloidosis, 
centrilobular necrosis or perilobular degeneration of the liver and haemorrhages 
of the brain and lungs (Mason et al. 1972, Bryson and Ellis 1976, Arbour et al. 
2012, Rees 1964, Fessler and Morter 1964). 
As the concept of feline leptospirosis is becoming more widely accepted, the 
use of up to date and efficient diagnostic tools is needed to further investigate 




1.3 Diagnosis of leptospirosis 
Leptospirosis presents with clinical and symptomatic similarities to other febrile 
illnesses and therefore can be confused with diseases such as Dengue or 
Malaria (Lindo et al. 2013). For this reason, a definitive diagnosis cannot be 
made from these observations alone. This disease also poses a threat to global 
health due to its worldwide distribution and potential to cause endemics (Sykes 
et al. 2011, Picardeau et al. 2014) and therefore it has been a necessity to 
develop an effective diagnostic tool to detect the disease at the earliest stage of 
progression to allow for rapid treatment and prevention of spread. Several 
reviews have evaluated the common findings found, and diagnostic techniques 
used, in leptospirosis (Schuller et al. 2015, Sykes et al. 2011, Ahmad, Shah 
and Ahmad 2005, Levett 2001).  
1.3.1 Non-specific laboratory findings 
Non-specific laboratory findings can be indicative of leptospirosis but would not 
be used to confirm infection. Investigations include haematology, biochemistry 
complete blood counts (CBC) erythrocyte sedimentation rate (ESR), white cell 
counts (WBC), liver function tests (LFT), urinalysis and CSF analysis, 
highlighted in one symposium and literature review (Ahmad et al. 2005, Levett 
2001). Results commonly observed with the disease may suggest impaired 
renal function (with or without azotaemia), impaired hepatic function (Icteric 
leptospirosis), leucocytosis, electrolyte imbalances and possible anaemia 
(Ahmad et al. 2005, Levett 2001, Sykes et al. 2011, Knopfler et al. 2017) with 
thrombocytopenia also being a common finding amongst dogs (Knopfler et al. 
2017, Kohn et al. 2010) . These findings may indicate infection, however do not 
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contribute to an aetiological diagnosis. Conventional diagnostic tests include 
direct microscopic demonstration, culture and serological tests. 
1.3.2 Dark-field microscopy 
Historically, diagnostic methods such as dark-field microscopy were used, in 
which blood or cerebrospinal fluid (CSF) were analysed in order to directly 
examine for the presence of bacteria in the samples (Levett 2001). 
Theoretically, due to the bacterial load in the blood during the acute stage (102-
106 Leptospira per ml), it was thought to be an effective way of detecting the 
Leptospira (Picardeau et al. 2014, Agampodi et al. 2012). However, further use 
of the technique since has revealed its limitations. This method would not be 
effective during the immune phase due to the absence of bacteria in the blood 
and it has also been demonstrated to be open to misinterpretation with low 
sensitivity and specificity (Levett 2001, Musso and La Scola 2013), with one 
study performed on the blood samples of humans with suspected leptospirosis 
reporting the specificity and sensitivity of this diagnostic technique as 61% and 
60%, respectively (Sharma and Kalawat 2008). 
1.3.3 Culture 
Isolation identification of leptospiral bacteria using culture techniques has 
previously been described as one of the gold standard methods of diagnosis 
(Picardeau et al. 2014). Either a urine, blood or CSF sample may be selected 
for culture but the presence leptospiral bacteria in each type of sample depends 
greatly on the stage of disease, making timings complicated (Ahmad et al. 
2005, Musso and La Scola 2013). One meta-analysis of four separate studies 
in Thailand, evaluated the sensitivity of culture alone as being 10.5% 
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(Limmathurotsakul et al. 2012) in the diagnosis of leptospirosis. It has been 
admitted that this method has little relevance in early diagnosis of the disease 
(Toyokawa, Ohnishi and Koizumi 2011) due to the slow growth rate of the 
bacteria, prolonged incubation times and expertise requirements (Ahmad et al. 
2005). Some have suggested that it would be a more effective diagnostic tool 
when used in combination with other methods (Tulsiani et al. 2011, 
Limmathurotsakul et al. 2012). 
1.3.4 Serology 
Serological tests have been found to be effective methods in diagnosing 
leptospirosis. This includes the microscopic agglutination test (MAT) and the 
IgM enzyme-linked immunosorbent assay (ELISA). The MAT is considered the 
reference method for serology (Musso and La Scola 2013) and involves mixing 
serial dilutions of patient sera with live antigens of known serovars and, once 
incubated, the samples are analysed under dark field microscopy in order to 
identify agglutinating clumps of Leptospira (Ahmad et al. 2005) . The highest 
serial dilution that shows agglutination with a minimum of 50% of the Leptospira 
is referred to as the ‘end–point titre’ and if this meets a certain cut-off value, the 
sample is identified as positive for leptospirosis (Ahmad et al. 2005, Ehsanollah 
and Gholam 2011). This method is limited due to the lack of a standardised cut 
off values amongst the different laboratories and those using lower values may 
allow for over diagnosis of the disease (Ahmad et al. 2005). The test is also 
vulnerable to misinterpretation, cross-reactivity, cross-contamination and the 
use of live antigens poses a health risk to personnel (Ahmad et al. 2005, Musso 
and La Scola 2013). This was demonstrated in the experimental infection with 
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Leptospira of young beagles in which MAT results would often showed highest 
titres to serovars differing from the ones purposefully inoculated into the dogs 
(Lizer et al. 2018), and this high level of cross reactivity was found in all 
serovars tested, except Hardjo. If the animal has recently been vaccinated, they 
may also show seropositivity to the serovars contained in the vaccine and may 
give false positive results (Martin et al. 2014). If the animal is infected with a 
serovar not present in the serovar panel of the test, this could in turn lead to 
false negative results (Sykes et al. 2011). Antibody production usually occurs 
after the leptospiraemic phase of the disease (Ahmad et al. 2005), during the 
second week of infection, and may not peak for 3-4 weeks and for this reason, 
this test may not be as effective in early diagnosis (van de Maele et al. 2008). 
Lizer et al. found seroconversion evident in 21/32 by day seven, later 
increasing to 30/32 by day 14 when using MAT (Lizer et al. 2018) when 
experimentally infecting dogs. Another time consuming factor that must be 
acknowledged concerning this method, is the common need for a fourfold titre 
rise in paired sera samples taken a few weeks apart, limiting use in acute cases 
of leptospirosis (Niloofa et al. 2015). 
IgM enzyme-linked immunosorbent assay (ELISA) is similar to MAT, developed 
from the latter to be used as a simpler, more rapid screening test, but detects 
antibodies to whole cell Leptospira (Picardeau et al. 2014, Ahmad et al. 2005). 
It’s specificity and sensitivity has been shown to vary and although it has been 
indicated to detect antibodies earlier than the MAT (Bajani et al. 2003), it gives 
no indication of infecting serovar (Picardeau 2013).  
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Due to the complexity of these more widely used serological tests, there was a 
need for a point-of-care test to allow for rapid diagnosis in practice. Recently, a 
lateral flow assay method detecting IgM antibodies has become available in 
Europe and studies have shown it may become an efficient method to promptly 
diagnose acute leptospirosis, with little effect of recent vaccination on result 
(Lizer et al. 2017, Lizer et al. 2018).  
1.3.5 PCR 
In recent years, polymerase chain reaction has become increasingly useful for 
diagnosing leptospirosis and tends to replace the serological techniques 
(Picardeau 2013). These methods target and amplify leptospiral DNA in 
samples in order to confirm presence of the bacteria (Harkin, Roshto and 
Sullivan 2003) and have been found to detect Leptospira prior to 
seroconversion (Brown et al. 1995), with studies detecting even small numbers 
of bacteria in blood and urine samples (Picardeau 2013). Real-time PCR 
assays using Taqman or SYBR technology have been found to be faster and 
more specific than regular PCR and so are more widely used (Picardeau 2013).  
1.1.1.1 Targeting genes present in all bacteria 
 
The 16S rRNA gene (rrs), the gyrB gene and the secY gene are universally 
found in all bacteria (Ellis 2014) and have been targeted using PCR for 
detection of Leptospira. 
One of the first target genes used in this method was that of the L. interrogans 
16S rRNA gene (rrs) (Merien et al. 1992). Although the introduction of this 
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assay highlighted its sensitivity and speed superior to that of other methods 
such as culture, it was unable to distinguish between pathogenic and non-
pathogenic species of Leptospira (Merien et al. 1992) and other studies since 
have also highlighted this shortcoming with positive PCR results reported for 
non-pathogenic strains of Leptospira when targeting this gene (Tansuphasiri et 
al. 2006, Thaipadunpanit et al. 2011). This method has also recently been 
found to amplify commensal or environmental bacteria in urine samples and so 
its sensitivity at detecting Leptospira alone was questioned (Fink et al. 2015).  
The gyrB gene corresponds to the DNA gyrase subunit B protein and when 
evaluating a PCR assay targeting the leptospiral gyrB gene (Slack et al. 2006), 
there was no obvious amplification from the strictly non-pathogenic or 
pathogenic/intermediate species but it was present in all the known pathogenic 
species. Its topology in the species, L. interrogans and L. kirschneri was found 
to be distinctly different to that of the 16S rRNA gene (rrs) on comparison, 
which could prove useful in species differentiation and could be explored 
further. 
The secY gene is a housekeeping gene (Bourhy et al. 2011) and has been 
conventionally targeted in leptospiral PCR assays using the G1/G2 primers 
(Cheema et al. 2007, Gravekamp et al. 1993). Studies have found that its 
amplification is specific to pathogenic leptospiral species (Ahmed et al. 2009), 
however there is also evidence to suggest that the assays used to target this 
gene may not be able to amplify the DNA from some of the pathogenic L. 
borgpetersenii (Bourhy et al. 2011), L. kmetyi (Bourhy et al. 2011)  and L. 
kirschneri (Gravekamp et al. 1993), as well as the DNA from the serogroup, 
26 
 
Grippotyphosa and Cynpteri, belonging to the species, L. interrogans (Parma et 
al. 1997). This proves to be a huge limitation, especially in terms of diagnosis in 
a clinical setting, and although some have used this set of primers targeting this 
gene in combination with others to detect pathogenic Leptospira (Cai et al. 
2002, Gravekamp et al. 1993), it would be more desirable to have one set of 
primers that efficiently detected the pathogenic Leptospira alone. 
The gene for OmpL1, a transmembrane outer protein (Haake et al. 2000), 
functions as a porin (Shang, Summers and Haake 1996). When developing 
primers to target this gene in leptospiral bacteria using arbitrarily primed PCR 
(AP-PCR), Reitstetter identified it in the majority, but not all, of the known 
pathogenic species (Reitstetter 2006). A study in China identified this gene in 
all the standard pathogenic strains as well as in 163 clinical strains of isolated 
pathogenic Leptospira (Dong et al. 2008). This study also found that the ompL1 
gene could be divided into three subgroups amongst the standard strains and 
Reitsetter and Haake et al. found a divergence of the ompL1 gene within the 
species, L. interrogans, splitting it into two groups (Reitstetter 2006, Haake et 
al. 2004). If explored further, these differences could prove useful in 
differentiating between pathogenic species and even serovars within the 
species. 
1.3.5.1 Targeting outer membrane proteins 
 
The genes for the outer membrane proteins, LigA and B, LipL21, LipL41 and 
LipL32 have all been investigated as target genes for leptospiral detection. 
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LigA and B are Leptospiral immunoglobin-like proteins suspected to be 
associated with leptospiral virulence (Matsunaga et al. 2003). Studies had 
shown primers targeting these genes to be specific to pathogenic Leptospira 
only (Bedir et al. 2010, Palaniappan et al. 2005). However, these investigations 
were limited to analysing pathogenic Leptospira belonging to L. interrogans and 
L.borgpetersniia and L.kirschneri and it would be useful to target serovars from 
other known pathogenic species to test overall efficiency. There is still little 
evidence surrounding this gene as a target for PCR assay, warranting further 
investigation. 
LipL41 is expressed during infection and has been found to be pathogenic 
specific (Shang et al. 1996). Studies have confirmed that this gene can be 
found in many serogroups belonging to L. interrogans (King et al. 2013) and 
other investigations into this gene have highlighted its conservation amongst 
pathogenic leptospiral species as well (Shang et al. 1996, Natarajaseenivasan 
et al. 2005). When using the hamster model, there have been differing reports 
as to whether it is essential during infection (King et al. 2013, Barnett et al. 
1999). Its questionable role during infection may hinder its efficiency as 
diagnostic tool and although some studies have advocated its use as an 
appropriate target gene for amplifying pathogenic Leptospira (Anitha et al. 
2012, Shang et al. 1996, Natarajaseenivasan et al. 2005), further investigation 
is required. 
The lipL21 gene, which encodes another lipoprotein, has also been found to be 
a reasonably efficient target gene for PCR, although there is very limited 
literature available. However, it has been disputed whether it is present in some 
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pathogenic serovars such as the Ballum serovar, belonging to L. interrogans 
(Meenambigai et al. 2011, Cheema et al. 2007) or the L.grippotyphosa species 
(Meenambigai et al. 2011), which would limit its use as a general diagnostic 
tool in pathogenic leptospirosis. 
The American College of Veterinary Internal Medicine (Sykes et al. 2011) and 
the British Small Animal Veterinary Association (Schuller et al. 2015) have both 
published consensus statements in the last eight years that highlight the 
efficiency of the lipL32 gene (coding for a main outer membrane lipoprotein), 
also known as the hap1 gene (Branger et al. 2005), as a target gene for PCR 
diagnosis of leptospirosis. Its expression during mammalian infection has been 
reported (Haake et al. 2000) and it has been associated with the development 
tubular nephritis in mice (Yang et al. 2002) . One study targeting this particular 
gene found the PCR assay to be 100% specific when analysing 218 laboratory 
strains of pathogenic Leptospira and showed no amplification in the non-
pathogenic strains (Cermakova et al. 2013), agreeing with other findings (Levett 
et al. 2005, Stoddard et al. 2009). Levett et al. also discovered inhibitory effects 
on the PCR assay when analysing whole blood samples due to addition of 
certain anticoagulants and recommended the use of tubes containing 
Ethylenediaminetetraacetic acid (EDTA) or citrate anticoagulants only. When 
experimentally infecting 12 beagles, Branger et al. also concluded that targeting 
LipL32, produced a positive sample in all dogs infected by day 4 post 
inoculation, in the presence of leptospiraemia (Branger et al. 2005).  
Many studies have experimented with various assays targeting this gene and 
there is very limited evidence available that draws any attention to any 
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limitations it may have. Some have proven a similarity in efficacy to targeting 
the lipL21 and secY genes (Cheema et al. 2007). Whereas in bovine studies, 
the lipL32 gene was amplified from all the pathogenic species studied in 
comparison to the lipL21 gene, which could not be amplified in one 
(Meenambigai et al. 2011). Another study found Taqman and SYBR green 
assays targeting the lipL32 gene to be of superior sensitivity to those targeting 
the secY or lfb1 genes (Bourhy et al. 2011) and when performing an endpoint 
dilution experiment, found that a SYBR green assay was of superior sensitivity 
to Taqman assays, when targeting lipL32. A very recent study further 
highlighted its use in diagnosing leptospirosis in the early stages of the disease, 
with its highest sensitivity in dogs with a lower MAT titre, which decreased as 
seroconversion progressed (Joseph et al. 2018).  
As demonstrated, there are plenty of available genes to target when diagnosing 
leptospirosis and each study has highlighted their limitations and the need for 
further investigation. If these were indeed explored further, it is plausible that a 
sensitive assay could be produced for each one of the possible target genes. 
Due to the wider availability of literature promoting the use of the lipL32 gene 
as a target for detection of pathogenic Leptospira, an assay targeting this gene 




1.3.6 Aims of this investigation 
Due to the limited amount of information regarding leptospiral infection in cats 
and the possible long-term clinical affects this may have, the study aimed to 
investigate the presence of leptospiral infection as a possible cause of CKD in 
cats, using qPCR as a diagnostic tool. The only study available investigating 
this relationship in cats performed PCR on the urine only (Rodriguez et al. 
2014). It was therefore decided to perform PCR analysis of Leptospira on whole 
blood samples in the current investigation to confirm an active leptospiral 
infection. It was also considered important to investigate possible effects 
leptospiral infection may have on the haematological, biochemical and urinary 
values in cats as well as to investigate the relationship between demographical 







2.1 Case selection criteria 
2.1.1 Origin of samples 
Samples for the study had been collected from the feline surgical and medical 
patient population of the small animal referral hospital and small animal practice 
at Langford Vets, Bristol between September 2016 and October 2017. These 
samples had been sent through the onsite diagnostic laboratory under the 
direction of the veterinary clinician involved in each individual case, to be used 
for various diagnostic testing.  
Only those cats that had had blood samples taken for a serum biochemistry 
profile and routine haematology profile, as well as a urine sample for a 
urinalysis, within a 24-hour period of each other were included, the results for 
which were all recorded. A minimum of 100µl of surplus whole blood sample 
was necessary to perform the PCR analysis.  If this was not available, the 
patient was excluded from the study. 
The whole blood samples of the patients were stored at 4°C for a period of 7-14 
days before DNA extraction commenced. The extracted DNA was stored at 4°C 




2.1.2 Categorisation of patients 
The cats were initially divided into two main groups: Kidney Disease (KD group) 
and Non-Kidney Disease (non-KD group). If it was unclear to which group the 
cat belonged to, it was placed into a ‘query group’, to be further analysed. This 
was done using biochemistry and urinalysis results and the IRIS staging of 
CKD in cats (IRIS 2015) as a guideline. This part of the process is displayed in 
stage 1 of the flowchart in Figure 1. Those with a urine specific gravity (USG) 
below 1.035 were placed in the KD group. Those with a USG equal or greater 
than 1.035 were then sorted according to the serum creatinine values. Those 
with a serum creatinine value <140mmol/l were placed into the non-KD group 
and those equal to, or above, that value were placed into a query group to be 
further analysed.  
Stage 2 of categorisation, as shown in Figure 1, was then used to organise the 
cats into groups of chronic kidney disease (CKD group) and non-chronic kidney 
disease (non-CKD group). The patient history, clinician case reports and further 
diagnostics results of the new groups were then examined and those which had 
one or more of the exclusion criteria (Section 2.1.3) were removed from the 
analysis. Due to the diagnosis of acute kidney injury being an exclusion factor, 
any cats remaining in the KD group were then able to be placed into the CKD 
group, as an acute condition has been ruled out. Any cats remaining in the non-
KD group were then placed into the non-CKD group. 
After the exclusion phase, the clinical history of any cats that remained in the 
query group were then analysed. Those with no obvious kidney impairment 
noted, and therefore no obvious renal cause of the elevated creatinine levels, 
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were placed into the Non-CKD group, and those with possible renal cause were 
placed into the CKD group. There were 5 cats in which the appropriate group 
was not obvious from the clinical records; these were then examined by an 
experienced clinician (Christina Maunder BVM&S CertSAM DipECVIM-CA 





Figure 1 Flowchart of the process of categorisation of cats into the CKD group or Non-CKD group
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2.1.3 Exclusion criteria 
When analysing the correlation between CKD and leptospiral positivity, certain 
factors that could be a primary cause of, or predisposing factor for, CKD, were 
reason for exclusion of those patients from this part of the study (Section 1.1.3), as 
were conditions that may lead to the misdiagnosis of CKD. This included the 
following: 
• Persian, Oriental, Himalayan, Exotic, Abyssinian or Somalian breeds 
(Lees 1996, Greco 2001, Beck and Lavelle 2001, Rodriguez et al. 
2014, Boyce et al. 1984)  
• Cats with reported ingestion of nephrotoxic substances such as lilies or 
ethylene glycol in the 3 months prior to the blood sample being taken 
(Fitzgerald 2010, Balakrishnan and Drobatz 2013, Reynolds and 
Lefebvre 2013) 
• Cats with confirmation of FIV-positivity during the investigations 
performed at Langford Veterinary Services during visit (Poli et al. 1995) 
• Reported evidence of previous or current urolithiasis/nephrolithiasis in 
the clinical notes or diagnostic imaging results (Reynolds and Lefebvre 
2013, Kyles et al. 2005) 
• Reported evidence of renal neoplasia in the clinical notes or diagnostic 
imaging results (Reynolds and Lefebvre 2013, Gabor et al. 1998, 
Gabor et al. 2000) 
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• Cats diagnosed with current acute kidney injury (AKI) stated in the 
case reports, discharge instructions or clinical notes to ensure cats 
included were suffering from chronic renal damage 
• Cats classified as biochemically hyperthyroid with a thyroxine value 
>60nmol/l (Wakeling et al. 2008, Adams et al. 1997a, Becker et al. 
2000, Williams et al. 2010, McLoughlin et al. 1993) 
Due to inconsistent history recording amongst the clinical notes, identifying cats that 
had received potentially nephrotoxic medications such as tetracycline, 
cyclophosphamide or non-steroidal anti-inflammatory drugs within the last 3 months 
(Papich 2005, Clark 1977, Sparkes et al. 2010, Sykes et al. 2011), proved difficult 
and therefore this was not used as an exclusion factor. 
When looking at the correlations between other variables and leptospiral positivity, 




2.1.4 Data collection 
In addition to the data collected for categorisation and exclusion of samples, the 
haematology, biochemistry and urinalysis results were recorded, as well as any 
virology or leptospiral serology results, if performed. Demographic information such 
as sex, age, neuter status, vaccination status, presence of other pets in the 






2.2.1 Sample collection 
Routine haematology and biochemistry profile analyses were performed on the 
whole blood sample (collected in a tube containing the anticoagulant, 
Ethylenediaminetetraacetic acid) and the serum sample of each cat, respectively, as 
well as a urinalysis of each cats’ urine sample. These tests were performed 
independently of this study. Cats were only included in the study if these were all 
performed within 24 hours of each other. The results of the tests, performed by the 
onsite diagnostics laboratory, were then used to confirm the absence or presence of 
CKD (Section 2.1.2, Figure 1), whilst only the whole blood sample was analysed 
using the PCR assay.  
2.2.2 DNA extraction 
2.2.2.1 Patient samples  
DNA was extracted from the samples using the DNeasy® Blood and Tissue Kit 
(QIAGEN; #69506). This was done so according to the ‘Purification of Total DNA 
from Animal Blood or Cells (Spin-Column Protocol)’ in the DNeasy Blood and Tissue 
Handbook (https://www.qiagen.com/gb/resources/resourcedetail?id=6b09dfb8-6319-
464d-996c-79e8c7045a50&lang=en). 100µl of each whole blood sample was used 
for DNA extraction. The steps for nonnucleated erythrocytes were followed and 
100µl of AE buffer used for the final elution process. 
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2.2.2.2 Positive and negative control 
DNA was extracted from a Nobivac® L4 vaccine (MSD; Lot A049A02; Exp 0-2019) 
using the same protocol as that used for the patient samples (Section 2.2.2). The 
active substances in this vaccination includes three inactivated Leptospira strains of 
serovars representing different serogroups within Leptospira interrogans species, as 
well as one strain of a serovar representing a serogroup within the Leptospira 
kirschneri species (Appendix 1). This was diluted to 1:10 with DNase and RNase 
free water. The negative control used for this study was DNase and RNase free 
water. Both controls were included in each Real-Time Polymerase Chain Reaction 
analysis performed. 
2.2.3 Real-Time Polymerase Chain Reaction  
2.2.3.1 Primers 
The following oligonucleotide primers and probe were designed by Dr Tristan Cogan 
at the University of Bristol and validated during preliminary tests (Section 3.1) with 
successful amplification of a section of the lipL32 gene, found in pathogenic species 
of Leptospira (Section 1.3.5.1). The primers and probe were used at a concentration 
of 10pmol/µl and 2 pmol/µl, and diluted 1:10 and 1:50 with DNase and RNase free 
water, respectively. 
Forward Primer:  E284f   5’ TTC GTA TGA TTT CCC CAA CC 3’  
Reverse Primer:  F407r  5’ CGG ATC CAA GTA TCA AAC CAA  3’ 
Probe:    FAM 5’ AGG CGA CGC TTT CAA AGC GG 3’ TAMRA 
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2.2.3.2 PCR assay 
The quantitative PCR analysis targeting the lipL32 gene was performed using the 
Stratagene Mx3005P qPCR System (Agilent Technologies) and the application of 
the ‘Quantitative PCR (Multiple Standards)’ experiment type with MxPro QPCR 
Software (Agilent Technologies; #41454) for the display and analysis of data. The 
reference dye utilised was FAM. 
A total reaction volume of 25µl made up of 12.5µl of 2X Brilliant III QPCR Master Mix 
(Agilent Technologies; #600880.5), 1µl of each oligonucleotide primer dilution, 0.5 µl 
of the probe dilution, and 10µl of extracted DNA sample, were used to amplify the 
target sequence. The negative and positive control were analysed with each test run. 
The optimal cycling conditions demonstrated by preliminary testing and used for all 
PCR reactions in this study commenced with a denaturation step at 95°C (10 
minutes) followed by 50 cycles of a further denaturation at 95°C (10 seconds) and an 
annealing step at 58°C (25 seconds).  
MxPro QPCR Software (Agilent Technologies; #41454) was used to display the 
results of the real-time PCR assay. Samples that tested negative for the presence of 
pathogenic Leptospira were displayed by a complete absence of Threshold Cycle 





2.2.4 DNA sequencing 
2.2.4.1 PCR product purification 
To verify PCR product identity, The QIAquick® Purification Kit (QIAGEN; #28104) 
was used according to the manufacturer’s instructions to purify the PCR products 
prior to DNA sequencing. 10µl of the PCR product was mixed with 50µl of Buffer PB 
as a starting volume. After processing the samples, 15µl of the eluted volumes were 
then premixed with 2µl of a 1/10 dilution of the forward primer (Section 2.2.3.1). 
The premixed samples were sent to the Eurofins Genomics Laboratory in Germany 
for sequencing.  
A small number of the sequences were aligned using CLC Sequence Viewer 7 and 




2.2.5 Statistical Analysis 
Statistical analyses were performed using GraphPad QuickCalcs software 
(https://www.graphpad.com/quickcalcs/contingency1) and IBM SPSS Statistics 24 
software, when investigating the association between all the identified variables 
against leptospiral positivity. Two types of analysis were used: A two-tailed Fisher’s 
exact test and Binary logistic regression analysis. 
When analysing the association between cats with CKD and leptospiral positivity, 
those that belonged to one of the exclusion criterion (Section 2.1.3), were removed 
and the two-tailed Fisher’s exact test analysis was performed on the two sets of data 
(Section 3.3).  
In order to explore the relationship between the different variables of all cats and 
leptospiral positivity (Section 3.4), both types of analyses were used depending on 
the data type. The two-tailed Fisher’s exact test was used when dealing with 
variables of binary value and the binary logistic regression was used when dealing 





3.1 Preliminary Data 
3.1.1.1 Sensitivity Panel 
The primers used in the PCR assay (Section 2.2.3) were tested against 15 other 
bacterium known to cause infection in small animals, as well as the negative and 
positive controls (Section 2.2.2.2). The only one that produced a positive result for 
the presence of pathogenic Leptospira was the positive control with a Ct value of 
34.49, as demonstrated in Table 3-1. 
 Table 3-1: Sensitivity panel results from the PCR assay used in the current study on the extracted DNA of 15 different 



















































3.1.1.2 Efficiency Curve 
Using DNA extracted from the L4 vaccine as a template, it was found that between 
levels of 10-1000 copies, the qPCR assay used in the current study has an efficiency 
of 89.1%, with an R2 of 0.9777, as shown on the efficiency curve displayed in Figure 
2. 
 




3.2 Threshold cycle number (Ct) of leptospiral positive 
samples 
In total, 24/158 cats (15.19%) cats were found to be leptospiral positive by qPCR of 
the whole blood sample, the Ct values of which are shown Table 3-2. Any value 
above zero represented successful amplification of the target sequence and the 
sample was considered leptospiral positive. In order to investigate the relationship 
between CKD and leptospiral positivity (Section 3.3), the cats were categorised as 
‘CKD’ or ‘non-CKD’, and those that fitted certain criteria were excluded from this 
analysis (Section 2.1.3). To study the relationship between other variables such as 
demographic information and blood and urine analysis results (Section 3.4), any of 
the previously excluded samples were then incorporated for these statistical 






Table 3-2: The threshold cycle number (Ct) of all the leptospiral positive cats and their allocated grouping 
 
  









































































3.3 Investigating the association between leptospiral 
positivity and chronic kidney disease in cats 
In total, 158 cats were recruited for this study. In order to investigate the correlation 
between leptospiral positivity and chronic kidney disease, 69 cats were excluded 
(Section 2.1.3). Reasons for this included the following: cats belonging to breeds 
predisposed to congenital kidney abnormalities (n=4), nephropathy of toxic origin 
within the last 28 days (n=1), reported evidence of renal neoplasia during sampling 
visit (n=1), reported evidence of current (n=18) or previous (n=14) (or both (n=7)) 
urolithiasis or nephrolithiasis, clinician has made a diagnosis of AKI in the final case 
report (n=8) and finally, those cats who were biochemically hyperthyroid 
(thyroxine>60nmol/l) (n=37). Some cats fitted more than one exclusion criterion.  
Of the remaining 89 cats, 56 (62.92%) belonged to the non-CKD group and a total of 
33 (37.08%) belonged to the CKD group. The CKD group consisted of 20 (60.61%) 
females and 13 (39.39%) males of ages ranging between 1-19 years (Mean age = 
11.55 years). The non-CKD group consisted of 30 (53.57%) females and 26 
(46.43%) males aged between 4 months and 17 years of age (mean age = 9.13). 
Table 3-3 demonstrates the number of cats with a leptospiral positive PCR result 
within these groups. 






    
CKD group 2 (6.06%) 31 (93.94%) 33 
Non-CKD group 6 (10.71%) 50 (89.29%) 56 
Total (n) 8 (8.99%) 81 (91.01%) 89 
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A two-tailed Fisher’s exact test analysis was performed on the values shown in Table 





3.4 Investigating the association between all other 
variables and leptospiral positivity 
3.4.1 Demographic variables 
The demographic variables are demonstrated in Table 3-4 and Table 3-5, including 
age, sex, neuter and vaccination status, presence of other animals in the household, 
access to outdoors and the breed. The total number of leptospiral positive cats within 
each variable group is also displayed. 
Binary logistic regression analysis was used to investigate the association between 
age and leptospiral positivity, as shown in Table 3-6. Leptospiral positivity was found 
to be significantly negatively associated with age, with a P value of 0.016.  
The two-tailed Fisher’s exact test was used to analyse the relationship between the 
demographic variables and leptospiral positivity, as shown in Table 3-7. The cats for 
which the information was not available were excluded prior to each statistical 
analysis. The same statistical analysis was performed to investigate the relationship 
between breed and leptospiral positivity, shown in Table 3-8. Nothing was found to 




Table 3-4: Demographic information of all cats 
Variable Total 
 
% of total (n=158) Leptospiral 
positive (% of 
variable total) 
Age 
≤ 5 years 33 20.89 10 (30.3%) 
6-10 years 42 26.58 4 (9.52%) 
> 10 years 83 52.53 10 (12.05%) 
Sex    
Female 88 55.70 10 (11.36%) 
Male 70 44.30 14 (20%) 
Neuter status    
Neutered 154 97.47 23 (14.94%) 
Entire 4 2.53 1 (25%) 
Vaccination status    
Up to date 71 44.94 16 (22.54%) 
Out of date/Never 14 8.86 1 (7.14%) 
Unknown 73 46.20 7 (9.59%) 
Other pets in household    
Dog 15 9.49 5 (33.33%) 
Cat 57 36.08 12 (21.05%) 
Other 1 0.63 0 (0%) 
None 7 4.43 0 (0%) 
Unknown 88 55.69 10 (11.36%) 
Outdoor access    
Yes 69 43.67 14 (20.29) 
No 10 6.33 1 (10%) 




Table 3-5: Total of cats belonging to each breed 
Variable Total 
 






Breed    
Domestic Short Hair 118 74.68 15 (12.71%) 
Domestic Long Hair 15 9.49 5 (33.33%) 
British Domestic Short Hair 2 1.27 1 (50%) 
Siamese 2 1.27 1 (50%) 
Maine coon 6 3.8 1 (16.67%) 
Birman 1 0.63 0 (0%) 
Ragdoll 3 1.9 0 (0%) 
Bengal 3 1.9 0 (0%) 
Burmese 2 1.27 0 (0%) 
Somali* 1 0.63 1 (100%) 
Persian* 1 0.63 0 (0%) 
Exotic* 0 0 - 
Himalayan* 0 0 - 
Oriental* 0 0 - 
Abyssinian* 2 1.27 0 (0%) 
Crossbreed 2 1.27 0 (0%) 










(B) Odds Ratio 
Age 1 0.016 -1.1720 0.179 
 












Sex     
Female 10 78 88  
Male 14 56 70 0.1804 
Total 124 134 158  
Neuter status     
Neutered 23 131 154  
Entire 1 3 4 0.4862 
Total 24 134 158  
Vaccination status     
Up to date 16 55 71  
Out of date/Never 1 13 14 0.2829 
Total 17 68 85  
Dogs in household     
Yes 5 10 15  
No 9 46 55 0.1607 
Total 
 
14 56 70  
Another cat in household     
Yes 12 45 57  
No 2 11 13 1.000 
Total 14 56 70  
‘Other’ pets in household     
Yes 0 1 1  
No 14 55 69 1.000 
Total 14 56 70  
Outdoor Access     
Yes 14 55 69  
No 1 9 10 0.6774 
















Domestic Short Hair     
Yes 15 103 118  
No 9 31 40 0.2002 
Total 24 134 158  




5 10 15  
19 124 143 0.0551 
t l 24 134 158  
British Domestic Short Hair     
Yes 1 1 2  
No 23 133 156 0.2815 
Total 
 
24 134 158  
Siamese
Siamese 
    
Yes 1 1 2  
No 23 133 156 0.2815 
Total 24 134 158  
Maine coon     
Yes 1 5 6  
No 23 129 152 1.000 
Total 24 134 158  
Birman     
Yes 0 1 1  
No 24 133 157 1.000 
Total 24 134 158  
Ragdoll     
Yes 0 3 3  
No 24 131 155 1.000 
Total 24 134 158  
Bengal     
Yes 0 3 3  
No 24 131 155 1.000 
Total 24 134 158  
Burmese     
Yes 0 2 2  
No 24 132 156 1.000 
Total 24 134 158  
Somali     
Yes 1 0 1  
No 23 134 157 0.1519 
Total 24 134 158  
Persian     
Yes 0 1 1  
No 24 133 157 1.000 
Total 24 134 158  
Abyssinian     
Yes 0 2 2  
No 24 132 156 1.000 
Total 24 134 158  
Crossbreed     
Yes 0 2 2  
No 24 132 156 1.000 
Total 24 134 158  
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3.4.2 Haematological variables 
Table 3-9 shows the haematology results for all the cats recruited for the study, 
grouped into those found to be leptospiral positive (n=24) and leptospiral negative 
(n=134), by PCR. This included the units and the reference intervals used by 
Langford Vets Diagnostics Laboratories as well as the range and mean values 
between the two groups. Also shown, are the number of cats for which the individual 
values were not recorded; these cats were excluded prior to statistical analysis. 
Binary logistic regression analysis was used to investigate the relationship between 
the haematological values and leptospiral positivity, as shown in Table 3-10. The 
values of statistical significance were lymphocyte and basophil count, both having a 
positive correlation to leptospiral positivity by PCR with P values of 0.029 and 0.032, 
respectively. 
Table 3-11 shows the results of the two-tailed Fisher’s exact test analysis used to 
investigate the association between haematological values outside of the laboratory 
reference interval (RI) and leptospiral positivity.  The variables with significant 
association to leptospiral positivity were lymphocytes and eosinophil counts above 
the RI (lymphocytosis and eosinophilia), with two-tailed P values of 0.0223 and 
0.0203, respectively. Monocyte and basophil count below the RI were not included in 





Table 3-9: Haematological values of all cats 
 Units Reference 
Interval 
PCR Positive cats (n=24) PCR Negative cats (n=134) 
Variable Range Mean value Not 
recorded 
Range Mean value Not Recorded 
Haematology 
Results 
        
Haemoglobin g/dL 8.10-14.20 4.2-13.7 10.34 0 3.4-15.6 10.97 1 
Red Blood cell x10^12/l 6-10.10 3.1-9.21 7.18 0 2.82-12.33 7.72 0 
Haematocrit  % 27.7-46.8 11.9-41.3 31.07 0 11.2-47.1 33.1 0 
White Blood Cell x 10^9/l 6.30-19.60 5.11-40.28 13.18 0 3.08-46.66 11.68 0 
Platelets  x 10^9/l 156-626 67-484 272.5 0 18-749 244.15 0 
Mean Cell Volume  fL 41.3-52.6 38.6-49.6 43.74 0 28.4-60.2 43.02 0 
Mean Cell 
Haemoglobin  




g/dL 27-32.8 31.7-35 33.34 0 30-36.8 33.09 1 
Neutrophils  x 10^9/l 3-13.4 2.08-26.81 8.48 0 1.73-41.54 8.38 0 
Lymphocytes  x 10^9/l 2-7.2 0.79-10.07 3.08 0 0.14-7.15 2.28 0 
Monocytes  x 10^9/l 0-1 0.08-1.21 0.4 0 0.03-2.62 0.34 0 
Eosinophils x 10^9/l 0.3-1.7 0-11.68 1.21 0 0-10.32 0.69 0 
Basophils  x 10^9/l 0-0.1 0-1.61 0.09 0 0-0.82 0.02 1 
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(B) Odds Ratio 
Haemoglobin 1 0.201 -0.518 0.596 
Red Blood 
Cells 
1 0.116 0.129 1.137 
Haematocrit 1 0.145 0.092 1.096 
White Blood 
cells 
1 0.372 -0.156 0.856 
Platelets 1 0.454 0.001 1.001 
Mean Cell 
Volume 
1 0.528 -0.015 0.985 
Mean Cell 
Haemoglobin 




1 0.360 0.301 1.351 
Neutrophils 1 0.970 0.130 1.139 
Lymphocytes 1 0.029 0.351 1.421 
Monocytes 1 0.426 0.021 1.021 
Eosinophils 1 0.092 0.100 1.105 





Table 3-11: Two-tailed Fisher's exact test analysis of haematological values outside of the reference interval (RI) vs 













Haemoglobin > RI     
Yes 0 7 7  
No 24 126 150 0.5960 
Total 24 133 157  




5 14 19  
19 119 138 0.1742 
t l 24 133 157  
Red Blood Cells > RI     
Yes 0 4 4  
No 24 130 154 1.000 
Total 
 
24 134 158  
Red Blood Cells < RI      
Yes 5 19 24  
No 19 115 134 0.3702 
Total 24 134 158  
Haematocrit > RI     
Yes 0 1 1  
No 24 133 157 1.000 
Total 24 134 158  
Haematocrit < RI     
Yes 5 21 26  
No 19 113 132 0.5524 
Total 24 134 158  
White Blood Cell > RI     
Yes 5 12 17  
No 19 122 141 0.1423 
Total 24 134 158  
White Blood Cell < RI     
Yes 4 22 26  
No 20 112 132 1.000 
Total 24 134 158  
Platelets > RI     
Yes 0 2 2  
No 24 132 156 1.000 
Total 24 134 158  
Platelets < RI     
Yes 6 53 59  
No 18 81 99 0.2518 
Total 24 134 158  
Mean Cell Volume > RI     
Yes 0 3 3  
No 24 131 155 1.000 
Total 24 134 158  
Mean Cell Volume < RI     
Yes 8 36 44  
No 16 98 114 0.6212 















Mean Cell Haemoglobin > RI     
Yes 2 8 10  
No 22 125 147 0.6510 
Total 24 133 157  
Mean Cell Haemoglobin < RI     
Yes 0 6 6  
No 24 127 151 0.5915 
Total 24 133 157  
Mean Cell Haemoglobin Concentration > RI     
Yes 18 80 98  
No 6 53 59 0.2517 
Total 24 133 157  
Mean Cell Haemoglobin Concentration < RI     
Yes 0 0 0  
No 24 133 157 1.000 
Total 24 133 157  
Neutrophils > RI     
Yes 5 19 24  
No 19 115 134 0.3702 
Total 24 134 158  
Neutrophils < RI     
Yes 2 5 7  
No 22 129 151 0.2879 
Total 24 134 158  
Lymphocytes > RI     
Yes 2 0 2  
No 22 134 156 0.0223 
Total 24 134 158  
Lymphocytes < RI     
Yes 9 70 79  
No 15 64 79 0.2676 
Total 24 134 158  
Monocytes > RI     
Yes 2 5 7  
No 22 129 151 0.2879 
Total 24 134 158  
Eosinophils > RI     
Yes 5 7 12  
No 19 127 146 0.0203 
Total 24 134 158  
Eosinophils < RI     
Yes 8 53 61  
No 16 81 97 0.6527 
Total 24 134 158  
Basophils > RI     
Yes 3 5 8  
No 21 129 150 0.1032 




3.4.3 Biochemical variables 
Table 3-12 summarises the biochemical values of all the cats recruited for the study. 
This included the range, mean values including the units used, as well as the 
reference intervals used by Langford Vets Diagnostics Laboratories, where the tests 
were carried out on the serum samples. These figures are displayed for the 
leptospiral positive cats (n=24) and leptospiral negative cats (n=134), respectively. 
Also shown are the number of cats for which the individual values were not recorded, 
these cats were excluded prior to statistical analysis. 
 As with the haematological values, a binary logistic regression analysis was 
implemented to investigate the relationship between the biochemical values and 
leptospiral positivity, shown in Table 3-13. The only value showing a significant 
association was alanine amino transferase, with a P value of 0.022, showing a 
positive correlation to leptospiral positivity. Phosphorus/phosphate, cholesterol and 
thyroxine levels were not included in this analysis due to insufficient number of cats 
for which these values were recorded. 
A two-tailed Fisher’s exact test was also performed on these values to investigate 
the relationship between biochemical values above or below the reference interval 
(RI) and leptospiral positivity, as shown in Table 3-14. Values of significance were, a 
total protein value below the RI with a two-tailed P value of 0.0290 and a total 
thyroxine value below the RI with a two-tailed P value of 0.0348, showing a negative 
association with leptospiral positivity. A significant positive correlation was also found 
between thyroxine value above the RI and leptospiral positivity with a two-tailed P 




Table 3-12: Biochemical values of all cats 
Biochemical values Units Reference 
Interval 
PCR Positive cats (n=24) PCR Negative cats (n=134) 
 Range Mean value Not recorded Range Mean value Not Recorded 
Biochemical values         
Serum Creatinine  µmol/l 133-175 23-1645 213.04 0 27-871 136.3 0 
Urea mmol/l 6.5-10.5 3.4-97.9 14.5 0 3.7-50 11.81 0 
Total Protein g/l 77-99 43.6-97.1 68.14 1 51-104.6 65.49 3 
Albumin  g/l 24-35 14.6-33.5 27.1 2 18.9-32.9 27.22 3 
Globulin  (g/l 21-51 29-75.1 41 2 23.1-85.2 38.27 3 
A:G Ratio   0.4-1.3 0.29-0.85 0.68 2 0.23-1.21 0.73 3 
Alanine aminotransferase  U/l 15-45 21-1845 181.26 1 22-729 105.73 3 
Alkaline Phosphatase U/l 15-60 4-483 65.7 1 1-309 50.7 3 
Sodium  mmol/l 149-157 147.2-159.6 154.5 9 124-168.8 153.83 31 
Potassium  mmol/l 4-5 3.61-4.76 4.25 8 2.74-5.6 4.26 31 
Chloride mmol/l 115-130 116-123 119.67 9 89-124 117.69 34 
Calcium mmol/l 2.3-2.5 1.74-2.82 2.45 
 
1 1.77-3.1 2.47 14 
Phosphorus/Phosphate** mmol/l 0.95-1.55 1.03-3.88 1.67 3 0.81-4.4 1.62 8 
Cholesterol** Mmol/l 3-6.9 2-9 4.44 15 2-7 3.9 116 
Thyroxine* ** nmol/l 15-60 25.9-393 160.13 11 12-749 84.17 49 
 
*A laboratory value of ‘<12.5’ was recorded as 12 for final analysis 
** These results were not included in the binary logistic regression analysis due to insufficient numbers of cats for which they were measured 
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(B) Odds Ratio 
Serum Creatinine 1 0.073 -0.013 0.987 
Urea 1 0.246 -0.062 0.940 
Total Protein 1 0.287 -0.045 0.956 
Albumin 1 0.664 0.367 1.444 
Globulin 1 0.339 -8.569 0.000 
Albumin to globulin 
ratio 
1 0.273 0.002 1.002 
Alanine 
aminotransferase 
1 0.022 0.003 1.003 
Alkaline phosphatase 1 0.102 -0.082 0.921 
Sodium 1 0.584 0.042 1.043 
Potassium 1 0.809 0.384 1.468 
Chloride 1 0.072 1.266 3.545 





Table 3-14: Two-tailed Fisher's exact test analysis of biochemical values outside of the reference interval (RI) vs leptospiral 












Serum Creatinine > RI     
Yes 4 26 30  
No 20 108 128 1.000 
Total 24 134 158  
Serum Creatinine < RI     
Yes 18 86 104  
No 6 48 54 0.3572 
Total 24 134 158  
Urea > RI     
Yes 9 59 68  
No 15 75 90 0.6566 
Total 24 134 158  
Urea < RI     
Yes 5 16 21  
No 19 118 137 0.3225 
Total 24 134 158  
Total Protein > RI     
Yes 1 1 2  
No 22 130 152 0.2772 
Total 23 131 154  
Total Protein < RI     
Yes 19 126 145  
No 4 5 9 0.0290 
Total 23 131 154  
Albumin > RI     
Yes 0 0 0  
No 22 131 153 1.000 
Total 22 131 153  
Albumin < RI     
Yes 2 14 16  
No 20 117 137 1.000 
Total 22 131 153  
Globulin > RI     
Yes 1 5 6  
No 21 126 147 1.000 
Total 22 131 152  
Globulin < RI     
Yes 0 0 0  
No 22 131 153 1.000 
Total 22 131 153  
A:G > RI     
Yes 0 0 0  
No 22 131 153 1.000 
Total 22 131 153  
A:G < RI           
Yes 1 2 3  
No 21 129 150 0.3744 




Table 3-14 continued 









Alanine aminotransferase > RI     
Yes 17 98 115  
No 6 33 39 1.000 
Total 23 131 154  
Alanine aminotransferase < RI     
Yes 0 0 0  
No 23 131 154 1.000 
Total 23 131 154  
Alkaline phosphatase > RI     
Yes 8 38 46  
No 15 93 108 0.6240 
Total 23 131 154  
Alkaline phosphatase < RI     
Yes 3 13 16  
No 20 118 138 0.7099 
Total 23 131 154  
Sodium > RI     
Yes 3 18 21  
No 12 85 97 0.7294 
Total 15 103 118  
Sodium < RI     
Yes 2 6 8  
No 13 97 110 0.2687 
Total 15 103 118  




0 9 9  
 
Tot 
16 94 110 0.6067 
Total 16 103 119  
Potassium < RI     
Yes 4 32 36  
No 12 71 83 0.7738 
Total 16 103 119  
Chloride > RI     
Yes 0 0 0  
No 15 100 115 1.000 
Total 15 100 115  
Chloride < RI     
Yes 0 9 9  
No 15 91 106 0.6031 




Table 3-14 continued  









Calcium > RI     
Yes 11 50 61  
No 12 70 82 0.6484 
Total 23 120 143  
Calcium < RI     
Yes 5 21 26  
No 18 99 117 0.5699 
Total 23 120 143  
Phosphate/Phosphorus > RI     
Yes 13 58 71  
No 8 68 76 0.2388 
Total 21 126 147  
Phosphate/Phosphorus < RI     
Yes 0 3 3  
No 21 123 144 1.000 
Total 21 126 147  
Cholesterol > RI     
Yes 2 2 4  
No 7 16 23 0.5815 
Total 9 18 27  
Cholesterol < RI     
Yes 1 2 3  
No 8 16 24 1.000 





Thyroxine > RI     
Yes 9 28 37  
No 4 57 61 0.0279 
Total 13 85 98  
Thyroxine < RI    
Yes 0 25 25  
No 13 60 73 0.0348 
Total 13 85 98  





3.4.4 Urinalysis variables 
The results of the urinalysis tests are shown in Table 3-15. The mean value, range 
and number of cats for which individual values were not recorded are shown for both 
the leptospiral positive cats (n=24) and leptospiral negative cats (n=134), as well as 
the units and reference intervals used by the Langford Vets Diagnostic Laboratories, 
where the tests were performed.  
Table 3-16 shows the range and mean urinary pH for cats with and without the 
presence of uroliths or nephroliths. 
A binary logistic regression analysis was performed to investigate the relationship 
between the urinalysis test results and leptospiral positivity by PCR of all cats 
recruited for the study. The results are displayed in Table 3-17. None of the test 

































0.65 0 0.03-7.3 0.38 0 
Glucose *** Scale 0-3 0-3 0.13 1 0-3 0.17 1 
Ketones*** Scale  0-3 0-1 0.04 1 0-1 0.03 1 








pH Scale  5.8-7.8 6.75 0 4.5-8.7 6.68 0 
 
*A laboratory value of ‘<8’ was recorded as ‘7’ for final analysis 
** A Laboratory value ‘< x’ was recorded as ‘(x - 0.01)’ for final analysis 
*** A Laboratory value of ‘Trace’ was recorded as ‘0.5’ for final analysis 
**** A Laboratory value of ‘>1.050’ was recorded as ‘1.060’ for final analysis 
 
Table 3-16: Urinary pH of cats with and without reported evidence of urolithiasis or nephrolithiasis 
Variable 
Cats with reported 
evidence or uroliths or 
nephroliths (n=17) 
Cats with no reported evidence 
or uroliths or nephroliths 
(n=141) 
Range Mean Range Mean 














(B) Odds Ratio 
Protein* 1 0.977 0.000 1.000 
Creatinine  1 0.122 0.38 0.951 
Protein/Creatinine 
Ratio** 
1 0.414 0.317 1.144 
Glucose *** 1 0.747 0.458 0.729 
Ketones*** 1 0.618 0.464 2.437 
Blood*** 1 0.618 0.406 1.158 
USG**** 1 0.376 0.359 1007567.414 
pH 1 0.628 0.119 1.147 
 
*A laboratory value of ‘<8’ was recorded as ‘7’ for final analysis 
** A Laboratory value ‘< x’ was recorded as ‘(x - 0.01)’ for final analysis 
*** A Laboratory value of ‘Trace’ was recorded as ‘0.5’ for final analysis 






3.4.5 Virology and serology variables 
The virology and serology results are displayed for the leptospiral positive (n=24) 
and leptospiral negative cats (n=134) in Table 3-18. Also shown are the number of 
cats belonging to each group for which these values were not measure/recorded, 
which is true for the majority. A two-tailed Fisher's exact test analysis of these values 
proved none of them to be statistically significant, as shown in Table 3-19. 
Table 3-18: Virology and serology results of all cats 
 
 













FIV positive     
Yes 0 1 1  
No 2 14 16 1.000 
Total 2 15 17   
FeLV positive     
Yes 0 0 0  
No 2 14 16 1.000 
Total 
 
2 14 16  
Leptospiral positive by MAT     
Yes 0 0 0  
No 1 1 2 1.000 
Total 1 1 2  
  
Variable 
PCR Positive cats (n=24) PCR Negative cats (n=134) 
Total Not recorded Total Not recorded 
Virology     
FIV positive 0 22 1 
 
119 
FeLV positive 0 22 0 120 
Serology     
Leptospiral positive 0 23 0 132 
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3.4.6 Other variables related to CKD 
Information gathered from the clinical histories of the cats for the categorisation 
process (Section 2.1.2) in order to investigate the relationship between CKD and 
leptospiral positivity are displayed for all cats in Table 3-20. The totals for each 
variable are shown for the leptospiral positive cats (n=24) and leptospiral negative 
cats (n=134), respectively. A two-tailed Fishers exact test was performed on each 
variable against leptospiral positivity by PCR, the results of which are also displayed 
in Table 3-20. The variables of statistical significance were presence of AKI (two-
tailed P value = 0.0192) and the presence of current uroliths or nephroliths (two-

















Acute Kidney Injury 
 
    
Yes 4 4 8  
No 20 130 150 0.0192 
Total 24 134 158  
Reported digestion of nephrotoxic substance  
ne 
    
Yes 1 0 1  
No 23 134 157 0.1519 
Total 24 134 158  
Current uroliths/nephroliths     
Yes 6 12 18  
No 18 122 140 0.0344 
Total 24 134 158  
History of uroliths/nephroliths     
Yes 2 12 14  
No 22 122 144 1.000 




3.4.7 Statistical Models 
Table 3-21 shows the results of a binary logistic regression analysis between age 
and presence of AKI. There was significant negative association with a P value of 
0.002.  








(B) Odds Ratio 






4.1 Investigating the association between CKD and 
leptospiral positivity 
The main aim of the current study was to investigate the presence of leptospiral 
infection in cats with chronic kidney disease. Although acute pathogenic leptospirosis 
has rarely been reported amongst cats, evidence of urinary shedding has been 
found (Rodriguez et al. 2012, Kim et al. 2008, Ferris and Andrews 1965, Larsson et 
al. 1985), as well as varying levels of seropositivity by MAT worldwide (Obrenovic et 
al. 2014). It was hypothesised that the kidney damage elicited by leptospiral infection 
commonly seen in dogs and humans, may also occur in cats, and this bacterial 
infection may be one of the many possible primary causes of CKD in cats. 
After excluding all the cats that showed evidence of other possible aetiology of CKD 
(Section 2.1.3), there was found to be no significant correlation between CKD and a 
positive PCR result for Leptospira in the blood (Two-tailed P value = 0.7049), when 
performing the two-tailed Fisher’s exact test analysis on the remaining sample 
number (Section 3.3). In fact, when analysing the data of all the cats included in this 
study, there was a significant positive correlation between leptospiral infection and 
acute kidney injury (AKI) with a two-tailed P value of 0.0192 (Section 3.4.6, Table 
3-20). Rodriguez et al. found that cats with AKI had a higher percentage of 
seropositivity than those with CKD or those considered healthy, although the 
significance of this was not reported, and it is unclear as to what a positive MAT 
result means in terms of active infection (Rodriguez et al. 2014). 
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Although infrequent, the reported cases of acute leptospiral infection in cats (Arbour 
et al. 2012, Mason et al. 1972, Bryson and Ellis 1976, Beaudu-Lange and Lange 
2014, Rees 1964, Harkness et al. 1970, Reilly et al. 1994) commonly demonstrated 
signs of AKI (Mugford et al. 2013). Clinical signs reported amongst these cats 
included, anorexia, lethargy, polyuria/polydipsia, haematuria and vomiting. Further 
investigations in some cases revealed azotaemia, abnormal kidneys on x-ray, 
interstitial nephritis and other indicators of AKI.  
The presence of L. Pomona using diagnostic tools was commonly found amongst 
these acute cases. For example, two of the three leptospiral positive cats described 
by Arbour et al had sudden onset of PUPD, as well as other kidney disease related 
clinical signs (Arbour et al. 2012). Both demonstrated abnormal renal values on 
serum biochemistry and USG, and abnormally sized kidneys on diagnostic imaging. 
After receiving antimicrobial therapy, all renal related clinical signs resolved, and 
kidney values on blood analysis returned to normal. The third cat of this report, had 
been developing clinical renal signs for several months (by which point, the kidney 
damage had become chronic) before rapidly deteriorating and euthanasia was 
performed. All cats tested positive for L. Pomona by MAT. Rees reported a cat that 
had presented to the author for treatment of interstitial nephritis which responded 
poorly to antibiotics. The cat soon developed jaundice and was also euthanased 
(Rees 1964) and MAT of the heart blood revealed seropositivity to L. Pomona. It 
could be pathogenesis in cats is serovar dependant (Hartmann et al. 2013).  
However, when experimentally infecting three cats with L. Pomona, Ferris et al. 
reported, that in spite of urinary shedding of the bacteria for over a month in one cat, 
it was not detected in the blood of these cats after 10 days post inoculation and there 
were no obvious clinical signs throughout the sixty day observation period, and the 
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bacteria could not be isolated from the kidney post mortem (Ferris and Andrews 
1965). Twenty years later, a similar study experimentally infecting cats via 
subcutaneous innoculation with L.icterohaemorrhagiae and L.canicola, extended the 
observation period to 77 and 84 days in two cats inoculated with the latter (Larsson 
et al. 1985). None of the cats elicited any clinical signs during the observation period, 
and bacterial cultures of the of the kidneys post mortem were negative for Leptospira 
in all cats. Others have also reported seropositivity amongst this species as having 
no clinical significance  (Obrenovic et al. 2014, Mylonakis et al. 2005, Azocar-Aedo, 
Monti and Jara 2014).  
Although the current study failed to demonstrate a significant relationship between 
CKD in cats and leptospiral positivity by PCR of the blood, it does not rule out 
leptospiral infection as a cause of CKD. The presence of Leptospira in the blood 
would imply active infection without an effective initiated immune response (Levett 
2001). This study found a significant correlation between AKI and a positive blood 
sample, as well as younger cats being more likely to demonstrate a PCR positivity 
(Two-tailed P value=0.016) (Section 3.4.1, Table 3-6). It is possible that cats become 
infected with leptospiral bacteria at a younger age, and the initial insult to the kidneys 
further develops throughout the lifespan of the cat, despite the development of an 
effective immune response clearing the initial infection and possible future transient 
infections, progressing into CKD as a geriatric. It could also be that, once the 
bacteria has been cleared from the blood, it colonises in the kidney tissue provoking 
continuous injury. In future investigations, it would be useful to sample the kidney 
tissue for isolation of the bacteria in order to explore this further. This was not 
possible during this study. Collection of urine samples for PCR testing, would also 
have given an indication of presence of bacteria within the kidneys, but due to 
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storage conditions and timings, this also was not possible but to be considered in the 
future. Rodriguez et al. also encouraged use of multiple diagnostic tests to enable a 




4.2 Investigating the association between demographic 
variables and leptospiral positivity 
Leptospiral positivity by PCR of the blood was significantly higher amongst younger 
cats in this investigation with a two-tailed P value of 0.016 (Section 3.4.1, Table 3-6) 
which was not found in relation to PCR of urine or seropositivity in the cats in a 
similar study . It was also found that younger cats were significantly more susceptible 
to acute kidney injury in the current investigation with a P value 0.002 (Section 3.4.6, 
Table 3-21). It could be possible that younger cats, whose kidneys are less 
developed, are more susceptible to bacterial invasion and subsequent kidney 
damage, which then facilitates the further adhesion of bacteria until an efficient 
immune response clears the bacteria from the body. Once this immune response 
has been initiated, the adapted defence mechanisms may then be efficient enough 
to avoid future infection by the bacteria which may be supported by other studies that 
have found a higher amount of leptospiral antibodies in older cats (Mylonakis et al. 
2005, Rodriguez et al. 2014). It is possible that initial kidney damage remains and 
progresses into CKD, most commonly found in geriatric cats. This would explain a 
negative PCR result for Leptospira in blood as there is no longer an active infection 
present in these older cats. 
Rodriguez et al. found that cats living with another cat in the household were more 
likely to be seropositive and it was suggested that the sharing of a litter tray may 
have been the transmission source (Rodriguez et al. 2014). There was no significant 
connection between PCR positivity in the current study and the presence of another 
cat in the household (Section 3.4.1, Table 3-7). It is not known how many of these 
cats have outdoor access and it would be assumed that toileting outside would 
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reduce this suggested transmission risk. However, it would also be expected that 
those cats that have outdoor access may have the added risk of contracting the 
infection from external environmental sources and from hunting infected prey 
(Schuller et al. 2015, Rodriguez et al. 2014), but access to the outdoors was not 
found to be significant in predicting leptospiral positivity (Section 3.4.1, Table 3-7).  
It is not surprising that this study did not find the presence of a dog in the household 
as significant (Section 3.4.1, Table 3-7), because although they would be living in 
close proximity of each other and leptospirosis is a common disease of the canine 
species, the majority of dogs tend to be vaccinated against it, with a recent report 
revealing 79% of pet dogs receive regular booster vaccinations in the UK 
(Anonymous 2017). There was also no significant correlation between the presence 
of a dog in the household with the seroprevalence of 124 domestic cats in Chile 
(Azocar-Aedo et al. 2014). 
It must also be considered that due to inconsistencies in types of questions asked by 
differing clinicians to the owners, a lot of the information regarding demographic 
variables was missing (Section 3.4.1, Table 3-4) making these sample numbers 




4.3 Investigating the associate between laboratory values 
and leptospiral positivity 
4.3.1 Haematological values 
When reviewing various published literature, the most common haematological 
findings in canine leptospirosis were neutrophilia, lymphopenia of varying degree 
and non-regenerative anaemia (Sykes et al. 2011). A European consensus 
statement agreed with these findings and also found monocytosis to be a common 
abnormality in canine infection (Schuller et al. 2015). Both literature reviews agreed 
that thrombocytopenia was another reason for differential diagnosis of leptospiral 
infection, when accompanied by acute kidney injury. Kohn et al. found that 58% of 
dogs with leptospirosis has thrombocytopenia reported on admission. De Silva et al. 
found thrombocytopenia in 80.7% at some stage of illness, with a peak being 
reported on the 5th day of fever (De Silva et al. 2014) when investigating human 
leptospiral infection. Its common occurrence amongst this species was also 
highlighted by others (Jaureguiberry et al. 2005, van de Werve et al. 2013). Anaemia 
and leucocytosis was reported in 50% or more of dogs at admission in another study 
(Kohn et al. 2010). The main findings of the current study associated a higher 
lymphocyte and basophil count, and eosinophilia, with leptospiral positivity amongst 
the cats investigated (Section 3.4.2).  
There is very limited available information surrounding the haematological effect of 
feline leptospirosis and therefore it is difficult to draw an effective comparison to the 
current study. In one feline case report, cats with clinical leptospirosis demonstrated 
neutrophilia, with a left shift and an elevated haematocrit value, or a milder 
neutrophilia alongside lymphopenia and moderate thrombocytopenia (Arbour et al. 
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2012) with the serovar Pomona. Lymphocytosis has been found in one case study in 
feline clinical infection with serovars belonging to the sejroë serogroup (Beaudu-
Lange and Lange 2014) 
In the current study, cats with deemed leptospiral positivity by PCR had a 
significantly higher number of lymphocytes (average = 3.08 x 10^9/l) in the blood 
than leptospiral negative cats (average = 2.28 x 10^9/l) (Section 3.4.2, Table 3-9) 
with a two-tailed P value of 0.029 (Section 3.4.2, Table 3-10). Lymphocytosis 
(lymphocyte count above in the reference interval) was present in 2/24 (8.33%) and 
0/134 (0%) of leptospiral positive and negative cats, respectively, and this was found 
to be significantly associated with leptospiral positivity with a two-tailed P value of 
0.0223 (Section 3.4.2, Table 3-11). Lymphopenia was reported in 9/24 (37.5%) of 
positive cats and 70/134 (52.24%) of negative cats and was not found to be 
significant (Section 3.4.2, Table 3-11).  
A consensus statement reported lymphopenia to be commonly associated with 
canine infection, and another study agreed with this and reported lymphocytosis in 
as little as 2% of canine patients (Kohn et al. 2010). Craig et. al measured 
lymphocytes in human patients at different stages of the disease and also found 
lymphopenia to be a common finding in patients with leptospirosis (Craig et al. 
2009). All patients in the acute phase (before an effective immune response was 
initiated) demonstrated lymphopenia and this level of incidence was less in those 
that were at the start of the immune phase and decreased even further in those 
classed in the immune phase of the disease. This was thought to be due to 
lymphotoxic exoproducts produced by the circulating Leptospira until an effective 
immune response clears them from the blood. There is not enough evidence to 
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suggest how long each of the different stages of leptospiral infection last in a cat and 
whether this would explain the pattern of lymphopenia amongst the cats in the 
current study. 
It could be that cats are repeatedly exposed to the bacterium, as demonstrated by 
varying seroprevalence worldwide (Section 1.2.1), allowing them to build up an 
effective immune response. An immune response that quickly recognises and acts 
against the Leptospira during infection would limit the period of opportunity for the 
bacterium to release the lymphotoxic substances, before being destroyed 
themselves by the leukocytes. 
The current study also showed that leptospiral positive cats had a significantly higher 
basophil count compared to the leptospiral negative cats with a P value of 0.032 
(Section 3.4.2, Table 3-10). The mean basophil count was 0.09 x 10^9/l and 0.02 x 
10^9/l in the positive and negative cats, respectively (Section 3.4.2, Table 3-9). 3/24 
(12.5%) of the positive cats and 5/134 (3.73%) of the negative cats had a basophil 
count value above that of the normal range (0-0.1 x 10^9/l), and this was not found to 
be significant (Section 3.4.2, Table 3-11). Basophils have mainly been linked to 
allergic, autoimmune and cancerous processes as well as organ rejection (Siracusa 
et al. 2013) so its association with leptospirosis is unclear and has not been reported 
in any other literature, with the exception of one equine study that found the level of 
basophils in horses with leptospirosis remained higher than that of healthy horse, 
within the first 5 weeks of the study, however the relevance of this was not reported 
(Sohail et al. 2017). The lack of association with an abnormally high basophil count 




There was also a significant association (two-tailed P value = 0.0203) found between 
eosinophilia and leptospiral positivity with 5/24 (20.83%) and 7/134 (5.22%) of 
leptospiral positive and leptospiral negative cats, respectively, demonstrating a value 
above the normal reference interval (Section 3.4.2, Table 3-11). One canine study 
found eosinophilia in only 2% of dogs with leptospirosis (Kohn et al. 2010). One 
clinical review compared eosinophils to neutrophils in that the respond to infection 
and initiate phagocytosis of bacterium (Ravin and Loy 2016) and this could explain 
the higher numbers seen in leptospiral infection. 
When analysing the platelet counts of the cats in the current study, there was no 
significant association found between this and leptospiral positivity when using the 
binary logistic regression analysis (Section 3.4.2, Table 3-10), nor when analysing 
platelet counts outside the RI using the two-tailed Fisher’s exact test (Section 3.4.2, 
Table 3-11). This contrasts to human and canine studies which have reported 
thrombocytopenia to be a common finding in leptospirosis (De Silva et al. 2014, 
Kohn et al. 2010, van de Werve et al. 2013, Jaureguiberry et al. 2005). Kohn et al. 
found this more commonly in dogs with pulmonary abnormalities secondary to 
leptospirosis (Kohn et al. 2010) whilst another study associated it with severe 
disease (Hochedez et al. 2015). Neutrophilia has also been associated as a clinical 
manifestation of severe disease in another study (De Silva et al. 2014), as well has 
having been reported as  a common finding in canine infection (Kohn et al. 2010, 
Prescott et al. 2002). There was no significant relationship between cats deemed 
leptospiral positive and neutrophilia in the current study (Section 3.4.2, Table 3-11). 
Additionally, when performing the binary logistics regression analysis on the 
haematological values of cats in the current study, there was also no significant 
association found between neutrophil count and leptospiral positivity with a two-tailed 
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P value of 0.970 (Section 3.4.2, Table 3-10). Only two of the cats from the sample 
number of the current study were suspected as having a possible leptospiral 
infection by the leading clinician during their stay in the hospital and sent for 
diagnostic evaluation of this, independent of this study. This would imply their 
symptoms were severe enough to raise suspicion and require testing for the disease, 
and although other cats were found to be leptospiral positive using the qPCR in this 
investigation, the disease progression may not have been as serious. however, 
when analysing the individual haematology results of these cats (results not shown), 
neither had neutrophilia or thrombocytopenia. It could therefore be that, unlike in 
canine infection, thrombocytopenia and neutrophilia are not a common consequence 
of feline leptospirosis, although there is not enough literature to compare this to. 
One study hypothesised that the effect on the vascular system may depend on the 
infecting serovar (Craig et al., 2013) and stage of disease (Craig et al. 2009). With 
limited information available of disease stage and progression in cats with 
leptospirosis, as well as the lack infecting serovar identification in the current study, it 
is difficult to explain the haematological changes seen in the cats included in this 




4.3.2 Biochemical values 
Common biochemical findings in canine leptospirosis tend to be those indicating 
kidney and liver dysfunction, with the larger majority of cases showing elevated 
serum and creatinine levels (Sykes et al. 2011). The current study found a significant 
correlation between alanine aminotransferase (ALT) levels, total protein levels below 
the RI and thyroxine levels above the RI, with leptospiral positivity, as well as 
thyroxine levels below the RI have a significant correlation to leptospiral negativity 
(Section 3.4.3). 
 Although the leptospiral positive cats in the current study showed a higher mean 
value of serum urea and creatinine values than that of the PCR negative cats 
(Section 3.4.3, Table 3-12), despite a reasonably strong positive correlation found 
between serum creatine levels and leptospiral positivity with a P value of 0.073 
(Section 3.4.3, Table 3-13), this was not found to be significant. Serum creatinine 
and urea values outside of the reference intervals for these biochemical 
measurements also showed no significant correlation to leptospiral positivity (Section 
3.4.3, Table 3-14).  This is interesting as AKI was found to be significantly associated 
with leptospiral positivity with a P value of 0.0192 (Section 3.4.6, Table 3-20) and 
increased serum creatinine levels are usually the main indicator of this state (Ronco, 
Kellum and Haase 2012). Arbour et al. reported one cat with clinical leptospirosis as 
having normal serum creatinine levels with a lightly elevated urea (Arbour et al. 
2012), despite demonstrating a very high titre of 1/12,800 for L. Pomona. This cat 
responded well to treatment and survived. The second cat described in the same 
paper presented with creatinine values within the reference range and a high MAT 
titre for L. Pomona and also survived after treatment. The third cat, however, 
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presented with severely elevated urea and creatinine levels, and despite treatment, 
deteriorated and was euthanased, Leptospira was confirmed by MAT and PCR on 
urine and renal tissue. The first two cats that responded to treatment had been 
showing clinical signs for no longer than two weeks, the third had been showing 
them for a few months. Hugely elevated creatinine levels may therefore be 
associated with the final stages of the disease, and it may take a few months to 
progress to this stage.  
A significant positive correlation of a P value of 0.022 (Section 3.4.3, Table 3-13) 
was found in the current study between Alanine aminotransferase (ALT) levels and 
leptospiral positivity on PCR when performing a binary logistic regression analysis. 
17/24 (70.83%) of the leptospiral positive cats and 98/134 (73.13%) of the negative 
cats had an ALT value above that of the laboratory reference range (14-45 U/l), 
although this was not found to be significant (Section 3.4.3, Table 3-14). In human 
medicine, abnormal serum ALT levels are considered a good indicator of liver 
disease (Kim et al. 2008). Mild increases, however tend to be ignored as are not 
considered clinically significant. Increases in ALT are less frequently seen than that 
of ALP and total bilirubin when analysing the serum biochemistry of dogs with 
leptospirosis (Schuller et al. 2015) and therefore its relevance in this study, when 
unaccompanied by a significant increase ALP or bilirubin, is unknown.  ALT is 
released from the liver as a consequence of hepatocyte injury or expiration (Kim et 
al. 2008).  
Liver dysfunction has been recognised in reported cases of feline leptospirosis, 
including indications such as the development of icterus (Mason et al. 1972, Rees 
1964) and the icteric form of leptospirosis has been acknowledged as a very severe 
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and progressive from of the disease (Levett 2001). Post mortem examination of liver 
demonstrated abnormalities such as gross enlargement, centrinobular necrosis, 
hepatic amyloidosis, parenchymal fatty changes or noted friability of the parenchyma 
(Bryson and Ellis 1976, Mason et al. 1972, Harkness et al. 1970). One study noted 
elevated liver enzymes in the majority of seropositive cats (Agunloye and Nash 
1996) with no obvious clinical signs related to this. It was hypothesised that elevated 
liver enzymes may be an early indicator of the disease and development of jaundice 
may occur in the final stages. In agreement with this idea, others have reported 
cause for euthanasia at this stage, as well as one cat dying due to unsuccessful 
attempts at treatment (Mason et al. 1972, Rees 1964). Icterus may also be related to 
L. Pomona infection (Bryson and Ellis 1976). However, some cats that have been 
highly seropositive to L. Pomona have shown no obvious liver implications (Arbour et 
al. 2012), as well as some experimentally infected with this serovar (Fessler and 
Morter 1964), but this could also be due to infection stages. Unfortunately, the 
Leptospira in the current study was not speciated to enable comparison. 
Another finding in the current study was a significant association between total 
protein value below the RI (77-91 g/l) and leptospiral negativity with a two-tailed P 
value of 0.0290 (Section 3.4.3, Table 3-14). This consisted of 19/23 (82.6%) of the 
positive cats and 126/131 (96.18%), with a total of 145/154 (94.16%) of all cats. It 
was difficult to find reason for this association but due to the large proportion of total 
cats with an abnormally low total protein value, this may indicate incorrect reference 
range of this test. 
9/13 (69.23%) leptospiral positive cats and 28/85 (32.94%) of leptospiral negative 
cats were reported to have thyroxine levels above the RI (15-60mmol/l) at the time of 
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blood sampling, confirming a significant positive correlation between biochemical 
hyperthyroidism and leptospiral positivity with a two-tailed P value of 0.0279 (Section 
3.4.3, Table 3-14). Biochemical hypothyroidism was reported in 0/13 (0%) and 25/85 
(29.4%) of leptospiral positive and leptospiral negative cats, respectively, resulting in 
a significant positive correlation between hypothyroidism and leptospiral negativity 
(Section 3.4.3, Table 3-14). These are novel and unexpected findings and there is no 
available literature to support them or help explain the mechanisms behind them. 
A review identified other common clinical biochemical findings, such as potassium 
and phosphate/phosphorus levels below and above normal, and abnormally low 
sodium and chloride levels (Schuller et al. 2015). None of these values were found to 
have a positive correlation to the leptospiral positive cats in the current study 
(Section 3.4.3, Table 3-13 and Table 3-14). This could be an indication of disease 





4.3.3 Urinalysis values 
Reviews of literature concerning canine leptospirosis confirm isothenuria and 
proteinuria as a common finding on urinalysis, as well as the presence of glucose 
and blood in the urine (Sykes et al. 2011, Schuller et al. 2015) but there is little 
evidence of urinary changes in cats infected with the bacteria. One study 
experimentally infected cats with L.interrogans and L.canicola and, in the 56 days 
post inoculation, no changes in urinary values were noted (Larsson et al. 1985) , 
although this could be due to incubation periods being longer to that of the 
observation period used in the experiment or serovar-specific effects on urine.  
There were no significant associations found between any of the urine values and 





4.3.4 Virology and serology variables 
There were no significant associations reported between leptospirosis and FeLV or 
FIV in this investigation (Section 3.4.5, Table 3-19). However, there was also a very 
low positivity reported of cats with these diseases and therefore not a large enough 
number to draw a reliable conclusion from. 
There was also not a significant association reported between a positive MAT result 
and for Leptospira and a positive PCR result (Section 3.4.5, Table 3-19). This is due 
to the fact that only 2/158 cats were tested for the presence of Leptospira by MAT 
and neither were deemed positive by this diagnostic method. This also highlights the 
lack of investigation into acute leptospiral infection as a cause of kidney dysfunction 
in cats as only 1/8 cats included in this study with AKI noted in the case report were 
tested for the bacteria. However, 3/8 of these cats were reported as either having 
ingested a nephrotoxic substance (n=1) or current urolithiasis or nephrolithiasis (n=2) 




4.3.5 Other significant findings 
This study showed a significant positive correlation between cats with current 
urolithiasis or nephrolithiasis and leptospiral positivity demonstrated by a two-tailed P 
value of 0.0344 (Section 3.4.6, Table 3-20). It was hypothesised that the pH changes 
involved that may encourage stone formation in the urinary system may also favour 
the conditions for leptospiral survival and colonisation.  A lower urinary pH optimises 
uric acid stone formation (Maalouf et al. 2004)  and calcium oxalate crystal formation 
(Cottam et al. 2002), whereas a urinary pH above 6.6 increases likelihood of struvite 
crystal form.  
In a study that analyses the movement of a saprophytic strain of Leptospira, motility 
of the bacteria increased in more alkaline environments (Islam et al. 2015). Lin et al 
investigated the effect pH has on the binding of the leptospiral immunoglobin-like 
proteins to the extracellular matrix components of host tissue cells and optimal pH 
for certain protein binding was between 4.5-8.5 (Lin et al. 2009). The acidic 
conditions within the urinary system that initiate some stone formation also reduce 
the motility of the Leptospira which could create more of an opportunity and time to 
bind to adjacent tissues within the kidneys. The range in pH optimal for binding of 
certain proteins means this environment would be favourable to tissue invasion.  
However, when analysing the urinary pH of the cats included in this study (Section 
3.4.4, Table 3-16), it was found that those with urolithiasis or nephrolithiasis reported 
at the time of blood sampling had an average urinary pH of 6.77 (range: 6.1-6.7) and 
those without had an average urinary pH of 6.68 (range: 4.5-8.7). With very little 




It is also a possibility that stone formation within the urinary tract is secondary to 
leptospiral infection. The urinary pH of those with mild leptospirosis (5.34 ± 0.22) and 
severe leptospirosis (5.55 ± 051) were both lower than those suffering from acute 
tubular necrosis in a study analysing the haematological and urinary findings in 
humans patients (Abdulkader et al. 1996). Although the mechanism for this effect on 
urinary pH is unclear, these acidic conditions could predispose these patients to 
urolithiasis/nephrolithiasis and the same could be assumed for the feline population 
in the current study. However, in the current study, the average urinary pH of cats 
that test leptospiral positive by PCR was 6.74 which was very similar to those which 
tested negative for leptospiral DNA in the blood which was 6.68 (Section 3.4.4, Table 
3-15). It is therefore difficult to understand the mechanisms behind this relationship.  
There was also no correlation found between cats with a previous history of 
urolithiasis and nephrolithiasis (excluding those with current stones reported) and 
leptospiral positivity (Section 3.4.6, Table 3-20).  
Unfortunately, due to storage conditions and timing restrictions, PCR analysis could 
not be performed on the urine of the cats and therefore evidence of the presence 
and colonisation of the bacteria within the kidneys could not be investigated. Nor was 





When analysing 158 cats, the current investigation found no significant association 
between chronic kidney disease in cats and leptospiral infection when using qPCR 
on whole blood samples (Section 3.3). However, by analysing a whole blood sample, 
a positive result would indicate the presence of leptospiraemia, an active infection in 
the blood before an effective immune response has been initiated. This study found 
a positive correlation between leptospiral positivity and AKI (Section 3.4.6) and 
therefore, it is still possible that this original insult could still cause enough kidney 
damage to go on to progress into chronic kidney disease, despite there not being 
evidence of active infection amongst these cats with the chronic condition. A 
leptospiral positive PCR result was also higher amongst the younger cats, which 
would support this idea, as at a younger age cats are more susceptible to novel 
infection by the bacteria (Section 3.4.1) before building up an effective immune 
response to target infection in the future. Therefore, Leptospira could still be one of 
the unknown causes of the common geriatric disease in cats. It is important to note 
that the IRIS staging of CKD usually requires the measurement of serum creatinine 
on at least two separate occasions (IRIS 2015). It was only possible to acquire one 
measurement of the cats included in this study, which could have led to the 
misdiagnosis of CKD.  
Overall, 24/158 (15.19%) cats were found to have a positive PCR result for 
Leptospira and there were patterns reported amongst haematology and serum 
biochemistry test results in cats with leptospiral positivity (Sections 3.4.2 and 3.4.3). 
For instance, cats with leptospiral positivity had significantly higher basophil and 
lymphocyte counts, as well as a higher alanine aminotransferase value in the serum. 
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When looking at patterns in values outside of the normal reference interval, 
leptospiral positive cats were significantly more likely to have eosinophilia, 
lymphocytosis, biochemical hyperthyroidism and a low total protein count. There 
were no significant findings amongst the urinalysis results (Section 3.4.4). 
There were also no significant findings amongst any of the demographic details 
recorded, including outdoor access, neuter or vaccination status, or presence of 
another dog or cat in the household (Section 3.4.1). Cats with current evidence of 
nephrolithiasis or urolithiasis were found to have a significant correlation to 
leptospiral positivity (Section 3.4.6), although the mechanism for this could not be 
explained. 
Although there were significant findings amongst the blood and serum test results of 
the cats in this study, the relevance of these could be disputed. A large limitation of 
this investigation was that the cats included were patients at the veterinary hospital 
and were suffering from a wide range of different medical or surgical conditions, 
which would also influence these test results. In order to fully evaluate the clinical 
relevance of feline leptospiral infection, healthy cats would need to be infected and 
the haematological, biochemical and urinary values, as well as clinical signs, 
analysed and monitored over a period of time and compared to a control group. The 
longest observation period recorded amongst experimentally infected cats is 
currently 84 days (Larsson et al. 1985). Since so little is known about leptospiral 
infection of cats, it would be ideal to extend this observation time and also to infect 
cats with different serovars and study the effects this may have. Post mortem 
analysis would also prove useful to evaluate direct effects the Leptospira may have 
on the organs.  
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It is apparent from case studies that the serovar Pomona may cause clinical disease 
in cats (Mason et al. 1972, Arbour et al. 2012, Rees 1964, Harkness et al. 1970), 
and has also been recently isolated from, and highlighted as a potential health threat 
to, livestock in the UK (Arent et al. 2017), and therefore may be of particular interest 
for future study of feline infection, as well as the potential for transmission risk. 
Another limitation of the current study was the ability to perform qPCR of whole 
blood samples only. Unfortunately, due to storage timings, and the ability for DNA 
degradation in urine at various temperatures (Morre et al. 1999, Cannas et al. 2009, 
Palmirotta et al. 2011), it was decided that this specimen type would not be used for 
PCR analysis in the current study. This analysis would provide more information on 
transmission risk from this domesticated species. PCR analysis of kidney tissue 
would also help evaluate the presence of Leptospira in renal tissue, especially when 
investigating the role of the bacterium in chronic kidney disease, however the 
sampling of this was not ethically feasible in the current study. All of these tests run 
together would help to paint a bigger picture of feline infection with Leptospira and 
should be considered to be performed in conjunction with each other in future 
experiments. 
Although, this study failed to demonstrate an association with leptospiral positivity 
and CKD in cats, its association with AKI could imply this acute condition is a clinical 
manifestation of the infection in cats. Younger cats were also found more likely to be 
leptospiral positive. It is possible that younger cats are more susceptible to infection 
by the bacterium and this can cause acute kidney damage before an effective 
immune response is elicited and prevents future infection. This initial insult to the 
kidneys may well progress into CKD as a cat gets older, despite there not being 
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evidence of active letpospiraemia at the time for diagnosis of the chronic condition, 
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